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 Cytochrome P450s are a common type of the polyketide tailoring enzymes that 
are responsible for the oxidation of polyketides.  PksS, a likely tailoring enzyme, is found 
within the gene cluster pksX, from Bacillus subtilis.  The gene cluster was found to 
synthesize bacillaene, a polyketide with antibiotic activity.  Sequence homology has 
classified pksS as a cytochrome P450.  We have hypothesized that PksS is responsible for 
the hydroxylation of bacillaene, dihydrobacillaene, or both.  After several attempts to 
clone, overexpress, and purify pksS, we determined a sequence error within the published 
sequence.  Following the determination of the correct sequence, the next in-frame stop 
codon was located.  Using this newly identified sequence, PksS was overexpressed 
successfully and assayed using a spectrophotometric cytochrome P450 assay that detects 
a carbon-monoxide complex with the ferrous form of the P450.  Spectra obtained 
definitively showed that PksS is a cytochrome P450. 
 Several steps have been taken to characterize the role PksS serves in the 
biosynthesis of polyketides by B. subtilis.  High-pressure liquid chromatography, coupled 
to mass spectrometry has preliminarily shown that the substrate for PksS is 
dihydrobacillaene.  Other attempts to construct mutations of pksS have been performed, 
but experiments with the mutant strains did not yield conclusive information.  
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CHAPTER I 
INTRODUCTION 
I.A  Polyketides 
 Polyketides are an important class of natural products that have complex forms 
and diverse biological functions.  Possessing a wide range of biological activities, 
polyketides are often used for their antibiotic and pharmacological properties (Castoe 
2007).  In recent years, three major types of polyketide synthases have been discovered, 
iterative polyketide synthases, modular polyketide synthases, and mixed aromatic 
modular polyketide synthases.  The iterative and aromatic polyketide synthases are found 
in fungal and bacterial strains (Bedford 1995; Tsoi 1995).  Complex modular polyketide 
synthases are commonly studied with respect to engineering novel polyketides through 
modification of their modular architecture (Stein 2005).  Several examples of natural 
polyketides are shown in the following figure.  
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FIGURE I.1 Examples of polyketide natural products (Floss 1999; Decker T. 2003; 
Altmann 2003 ; Ray 2004; Xie 2006) 
 
The first polyketide shown, erythromycin, is an antibiotic isolated from 
Saccharopolyspora erythraea.  This macrolide has also been used as a model polyketide 
for the generation of new antibiotics (Ray 2004).  Rapamycin, often administered to 
patients receiving organ transplants, is another important polyketide.  This polyketide has 
the activity to inhibit cell cycle progression and the growth of tumor cells (Decker T. 
2003).  Another therapeutic polyketide, Epothilone B, is a 16-membered macrolide that 
has shown anticancer activity.  This polyketide promotes tubulin polymerization in vitro 
and the stabilization of microtubles against Ca+2-dependent depolymerization (Altmann 
2003 ).  In 1959, the discovery of rifamycin made a large impact on the pharmaceutical 
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industry for patients suffering from mycobacterial infections.  Rifamycin B has been 
administered to patients suffering from tuberculosis, leprosy, and mycobacterial 
infections related to AIDS/HIV (Floss 1999).  Lovastatin, shown in figure I.1, is another 
theraputic agent that has been used to assist in irregular cholesterol levels.  Lovastatin has 
been administered to patients to increase the levels of low density lipoprotein activity 
leading to the decrease in cholesterol synthesis (Xie 2006).   
The structural diversity of polyketides can be explained with an understanding of 
the mechanism of polyketide synthases.  The polyketide synthases have been classified as 
Type I, Type II, and Type III, depending on their architecture, and biosynthetic 
mechanisms (Castoe 2007).   
The Type I polyketide synthases are a diverse group of multifunctional enzymes.  
They contain the activites required to complete a cycle of β-keto acyl chain elongations.  
Within the Type I classification, there are two subgroups dividing the synthases by 
enzymatic activity and the type of host organism (Castoe 2007).  Modular polyketides are 
produced in bacteria in which the synthases contains one or more modules.  Each module 
is used once during the biosynthesis and is responsible for the production of one β-keto 
acyl group through a decarboxylation Claisen condensation between a malonyl derivative 
and the nascent polyketide chain.  In iterative synthases, found in fungi, the modules are 
used repeatedly and are responsible for chain elongation through the formation of β-keto 
acyl groups (Castoe 2007).   
The most common types of enzyme domains used in the Type I synthases are 
ketoacyl synthase (KS), acyl transferase (AT), ketoreductase (KR), dehydratase (DH), 
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enoyl reductase (ER), and thioesterases (TE).  Minimal modules contain the KS, AT, and 
the acyl carrier protein (ACP) (Castoe 2007).  This group is responsible for lengthening 
of the polyketide through the addition of acyl groups.  The chains are then reduced using 
KR, DH, and ER.  The polyketide is released from the PKS by a thioesterase, by 
hydrolysis or macrolactonization (Castoe 2007).   
Type II and Type III synthases differ from Type I synthases in the position of the 
enzymatic activities.  Type II synthases have arranged their synthases in separate 
polypeptides and use them repeatedly for chain elongation.  In contrast, Type III 
synthases are arranged as single multifunctional modules and lack the 
phosphopantetheine (Castoe 2007).  The phosphopantetheine is responsible for the 
transfer of the thiol from CoA from one active site to another.   
I.B.  Polyketide Biosynthesis 
I.B.1.  Erythromycin 
 The widespread use and studies of erythromycin (Figure I.2) have made it a 
model polyketide, for an understanding of polyketide biosynthesis.  The polyketide has 
been used in therapeutic practices to inhibit the growth of Gram-positive bacteria (Lee 
2004).  Since the discovery of erythromycin in 1952, it has been used as a model 
compound in developing new antibacterial polyketides (Lee 2004).  The structure of 
erythromycin is a polyketide core with two sugars, L-mycarose and D-desoamine, 
attached at the C-3 and C-5, respectively, shown in figure I.2 (Pereda 1998).  The 
hydroxyl groups at C-6 and C-12 are a result of hydroxylation by cytochrome P450 
enzymes. 
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FIGURE I.2  Erythromycin and 6-Deoxyerythronolide B (Lee 2004) 
  
 
 
 The precursor to erythromycin, 6- Deoxyerythronolide B, DEB, is synthesized 
from the 6- Deoxyerythronolide synthases, DEBS, which is a Type I modular polyketide 
synthase which contains 6 DEBS loading modules.  Each module is responsible for the 
elongation of the chain, leading to the production of DEB (Pereda 1998).  
 The synthesis of DEB begins at the N-terminus in which the loading acyl 
transferase transfers a propionate from propionyl Co-A to the loading acyl carrier protein 
domain, shown in figure I.3 (Pereda 1998).  From here, the propionate is transferred into 
module one in which a ketosynthase (KS1) extends the propionate by a Claisen 
condensation with (2S)-methylmalonyl-CoA.  The β-ketone thus formed is reduced by a 
ketoreductase forming a β-alcohol (Pereda 1998).  The following modules repeat the 
same Claisen reaction in which a total of six (2S)-methylmalonyl-CoA are added to the 
chain with some slight variation.  Modules 1, 2, 5, and 6 leave alcohols on the  final 
chain.  However, module 3 does not contain the KR, while module 4 contains all three 
auxiliary domains, KR, DH, and ER.  The lack of the KR in module 3 results in a ketone, 
and module 4 leaves a fully saturated group.  After the chain is extended and processed 
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by module six, the polyketide is released by a macrolactonization catalyzed by the 
thioesterase (Pereda 1998).  This produces the precursor to erythromycin, DEB.      
 
 
 
FIGURE I.3 Biosynthesis of 6- Deoxyerythronolide (Pereda 1998) 
   
 
 The precursor is hydroxylated by EryF at C6, followed by the addition of L-
mycarose at C3 by EryBV, shown in figure I.4.  The next step is the addition of D-
desoamine to C5 by EryCIII (Lee 2004).  At this point, erythromycin D can follow two 
different pathways.  The preferred pathway in the synthesis of erythromycin A is the 
hydroxylation of C12 by EryK, a cytochrome P450, followed by the methylation of L-
mycarose by EryG forming erythromycin A (Lee 2004).  The second pathway involves 
the methylation of L-mycarose on erythromycin D and then the hydroxylation at C12 by 
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EryK.  Although both pathways are possible, kinetic experiments show a 1000 fold 
preference for the first pathway (Lee 2004).   
 
 
 
FIGURE I.4 Biosynthesis of Erythromycin from 6- Deoxyerythronolide (Lee 2004) 
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I.C. Bacillaene 
I.C.1 Bacillaene Biosynthesis 
 Bacillus subtilis has been responsible for the production of at least 3 polyketides.  
Furthermore, the completion of its genomic sequence was accomplished in 1997.  The 
genome project resulted in the discovery of a 15-gene operon, pksX.  The product of the 
pksX cluster was later identified as bacillaene (Butcher 2007). 
 Bacillaene was isolated in 1994 by Patel, et. al., from Bacillus subtilis and in 2006 
by Chen et. al. from Bacillus amyloliquefaciens strain FZB 42 (Patel 1995; Chen 2006).  
The antibacterial activity of bacillaene has been studied because of its effectiveness in 
both Gram-positive and Gram-negative bacteria.  Research has shown that bacillaene’s 
activity when inhibiting protein synthesis for prokaryotic cells is high, however, it does 
not contain the ability to inhibit eukaryotic protein synthesis (Chen 2006). 
Despite its first isolation in 1994, the structure of bacillaene was not solved until 
2007.  Any attempts to characterize bacillaene have been impeded by its instability in 
light and room temperature (Butcher 2007).  Recently, the collaboration of two different 
techniques has made the structure of bacillaene available.   After making pksX mutations 
of Bacillus subtilis, COSY and ROSEY NMR were used to monitor any changes 
exhibited on the spectra of partially purified bacillaene.  After overlapping several 
spectra, the structures of bacillaene and dihydrobacillaene was finally determined, shown 
in figure I.5 (Butcher 2007).   
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FIGURE I.5 Structure of bacillaene and dihydrobacillaene  (Butcher 2007) 
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Gene knockout experiments have shown that the gene operon pksX is responsible 
for the production of bacillaene and dihydrobacillaene (Butcher 2007).  Table I.1 and 
Figure I.6 detail the location of each gene within the operon and their proposed functions.  
The operon contains 5 polyketide synthases, two of which also contain NRPS domains.  
The acyltransferase activities needed by these synthases are believed to be supplied by 
the free-standing proteins, pksCDE (Chen 2006).  
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Table I.1 Function of Polyketide Synthases for Cluster pksX (Chen 2006) 
Gene Name Function based on Homology 
pksA Transcriptional Regulator 
pksB Zn-dependent hydrolase 
pksC-D Acyl Transferases (AT) 
pksE Acyl Transferase with flavin mononucleotide-dependent oxidase 
acpK Acyl Carrier Protein Transferase (ACP) 
pksF Ketosynthase 
pksG Hydroxymethylglutaryl (HMG)- CoA Synthase 
pksH-I Enol CoA Dehydrases 
pksJ-R Acyl Transferase-Less Type 1 Polyketide Synthases (PKSs) 
pksS Cytochrome P450 (hydroxylase) 
 
 
 
Figure I.6 Gene Cluster pksX (Chen 2006) 
 
 
 
 
 
The biosynthesis of bacillaene, shown in figure I.7, begins with the gene pksJ,.  
The first step is to load an α-hydroxyl-isocaproic acid onto the chain by pksJ.  The next 
module provides the addition of a glycine by a NRPS condensation (c) domain .  A 
malonyl group from malonyl CoA is then transferred onto the thiolation domain of the 
next module, and the KS domain adds it to the nascent chain, forming β-ketoacyl group.  
The ketone is reduced to an alcohol using ketoreductase.  Using dehydratase, the alcohol 
is eliminated to an alkene.  If the production of dihydrobacillaene is a result of the pksX 
gene cluster, it is believed that at this point, an unknown reductase is used to reduce the 
double bond (Butcher 2007).  The most likely synthase responsible for the reduction that 
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is also present in the pks gene cluster is pksE.  Regardless of whether the bond is reduced 
or not, the biosynthesis of bacillaene continues with the addition of malonyl CoA for a 
chain-extension by ketosynthase.  The ketone is then reduced to an alcohol by a 
ketoreductase (Butcher 2007).   
 
 
FIGURE I.7 Biosynthesis of Bacillaene;  (Butcher 2007) 
 
Abbreviations:  KS, ketosynthase; AT: acyltransferase; T, Thiolation; DH, dehydratase; 
KR, ketoreductase; MT, methyltransferase; A, adenylation; C, condenstation; Atd, AT-
docking; Hyd, Zn-dependent hydroxylase; Ox, flavin mononucleotide-dependent oxidase; 
HCS, HMG-CoA synthase; ECH, enoyl-CoA hydratase/isomerase; TE, thioesterase 
 
  
 
 
The chain is elongated two more times using malonyl Co-A groups, until reaching 
the tandem thiolation domain within pksL (Butcher 2007).  These T-domains recruit 
several proteins, acpK and pksCFGHI, which are responsible for the installation of a β-
11 
 
 
branching carbon at C9’.  The first step catalyzed by the subcluster is the addition of a 
malonyl CoA group to acpK by pksC.  The malonyl group is decarboxylated by pksF to 
yield acetyl-acpK (Butcher 2007).  The next gene, pksG, is expected to be the cause of 
the unusual subunit because of its homology with HMG-CoA synthase.  An enoyl-CoA 
hydratase/isomerase is used to eliminate the hydroxyl group resulting in a double bond.  
The protein pksI decarboxylates the intermediate to form the final β-branch (Butcher 
2007).  After the formation of this unit, the chain is continuously elongated by remaining 
genes in the operon, pksM, pksN, and pksR complete the biosynthesis of bacillaene.  The 
genes code for the addition of several malonyl units, followed by the reduction of β-keto 
acyl groups to alcohols.   The chain is released from the PKS by the thioesterase (Butcher 
2007).   
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FIGURE I.8 Subcluster within pksL (Butcher 2007) 
 
 
 
 
A second species that has been known to produce bacillaene is from Bacillus 
amyloliquefaciens, strain FZB42 (Chen 2006).  This strain codes for three different gene 
clusters, in which one large cluster, bae, has been shown to be required for the 
biosynthesis of bacillaene in this species.  The cluster is arranged nearly identically as the 
pksX from B. subtilis. The high degree of homology seen suggests that there is a common 
ancestor of the pks/bae cluster (Chen 2006).  Figure I.9 and Table I.2 detail the function 
and position of each gene within the operon.     
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TABLE I.2 Function of Polyketide Synthases for Cluster bae (Chen 2006) 
 
Gene Name Function based on Homology 
baeB Zn-dependent hydrolase 
baeC-E Acyl Transferases (AT) 
baeF ACP 
baeG Hydroxymethylglutaryl (HMG)- CoA Synthase 
baeH-I Enol CoA Dehydrases 
baeJ-R Acyl Transferase-Less Type 1 Polyketide Synthases (PKSs) 
baeS Cytochrome P450 (hydrolase) 
 
 
 
FIGURE I.9  bae gene cluster (Chen 2006) 
 
 
 
 
 
A common gene found within both pksX and bae, is pksS, which is transcribed in 
trans from the other genes.  Through sequence homology, pksS has been identified as a 
cytochrome P450.  As a cytochrome P450, it is hypothesized that pksS acts as a 
hydroxylase in the polyketide biosynthesis by those two Bacilli.   
By identifying pksS as a cytochrome P450, it will be possible to apply data to 
other novel polyketide systems.  This can lead to determination and characterization of 
other polyketides with therapeutic capabilities.  Also, information relating to the gene 
cluster that produces bacillaene could lead to more information concerning the potency 
and functionality of the polyketide.  Data recorded on the functionality of pksS as a 
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cytochrome P450 will be applied to developing a richer database of information for the 
field.   
I.C.2. Role of PksS in the polyketide synthesis of bacillaene  
Although the actual role of PksS in the polyketide biosynthesis of bacillaene has 
not yet been determined, sequence homology has allowed for the development of two 
hypothetical roles.  Using sequence homology, PksS has been hypothesized to be a 
cytochrome P450, in which it acts as a hydroxylase.   
 The first hypothesis assumes that an unknown reductase, possibly pksE, reduces 
bacillaene to dihydrobacillaene.  Once dihydrobacillaene is produced, pksS hydroxylates 
C14 forming an alcohol group.  The reaction is shown in figure I.10. 
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FIGURE I.10. Hypothesis 1 for the role of pksS in polyketide synthesis 
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The second hypothesis assumes that dihyrdrobacillaene is produced first by the 
pksX polyketide synthases.  After the production of dihydrobacillaene, it is possible that 
pksS hydroxlates the polyketide forming a hydroxylated version of dihydrobacillaene.  
The removal of water by some unknown dehydratase would form bacillaene, shown in 
figure I.11.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
 
 
FIGURE I.11. Hypothesis 2 for the role of pksS in polyketide synthesis 
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Although the two hypotheses for the role of pksS occur at different locations of 
the polyketide biosynthesis, the pathways reactions expected for pksS are expected to be 
quite similar.  We believe that PksS, a cytochrome P450, is brought to the Fe (V) state by 
a catalytic cycle involving a reductase that is well-known for cytochrome P450s (Ortiz de 
Montellano 2005).  When the iron center comes into contact with the C14/C15, an 
alkane, the oxygen removes a hydrogen, producing a radical on C14’.  This radical then 
forms a bond with the alcohol group, eventually removing the substitutent from the heme.  
This generates a hydroxyl group on C14 and a ferric center of the cytochrome P450.  The 
mechanism for this reaction is shown below in figure I.12 (Ortiz de Montellano 2005).  
Because the mechanism of hydroxylation has not yet been positively identified, several 
possible pathways to generate the hydroxyl group have been included in the figure.   
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FIGURE I.12.  General reaction of PksS in polyketide synthesis (Ortiz de Montellano 
2005) 
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I.D. Cytochrome P450  
Cytochrome P450 is a large class of enzymes that are responsible for the catalysis 
of many important oxidation reactions.  Although the mechanisms of cytochrome P450s 
are well understood, several questions remain unanswered about the selectivity of the 
hydroxylation of the hydrocarbon.  The main interest in cytochrome P450s is their ability 
to react with highly inert compounds, such as hydrocarbons (Carey 2003).  Although 
these questions have begun to be answered, information determined here could lead to 
identifying the mechanism for the reactivity of cytochrome P450s.   
Their structure is characterized by a signature iron center surrounded by a 
porphyrin ring, shown in figure I.13 (Berg 2002). This iron center is the reaction center in 
cytochrome P450 reactions.  During a typical cytochrome P450 reaction, molecular 
oxygen is used to activate the iron.  At a resting state, the iron center has an oxidation 
state of III (Berg 2002).  Through action of a reductase, the iron center is reduced to II at 
which point molecular oxygen bonds as well as several other small ligands including 
carbon monoxide.  The binding of carbon monoxide leads to a shift in its Soret Peak from 
420 nm to 450 nm.  This shift is the trademark reaction in identifying cytochrome P450s 
in biological systems (Ortiz de Montellano 2005).   
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FIGURE I.13. Iron (III) protoporphyin IX with a cysteine ligand 
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The general activation of molecular oxygen and transfer by a cytochrome P450 is 
shown in figure I.14.  The mechanism for the activation has been determined through the 
monitoring of intermediate states by spectroscopic techniques.  The activation of oxygen 
is begun through the binding of a substrate, identified as R-H, to the cytochrome P450 
enzyme (Ortiz de Montellano 2005).  The enzyme then accepts an electron from a 
reductase, resulting in the reduction of a ferric center to a ferrous center, at which point 
molecular oxygen binds.  The ferrous-oxy complex is further reduced through the 
addition of another electron forming a Fe (III)-hydroperoxy complex (Ortiz de 
Montellano 2005).  The peroxy-bond is cleaved by protonation of the terminal oxygen, 
releasing water and forming the iron IV-oxo porphyrin π-cation radical intermediate.  The 
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hydroxylated product, once formed, is then released and the cytochrome P450 is 
regenerated to its Fe (III) state (Ortiz de Montellano 2005).   
 
 
FIGURE I.14. Catalytic cycle for oxygen activation and transfer by cytochrome P450, 
molecular oxygen is represented by and asterisks (Ortiz de Montellano 2005)  
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The highly active centers are also known to catalyze several reactions used in 
polyketide synthesis and other metabolic pathways.  A list of common reactions 
catalyzed by cytochrome P450s is listed in Table I.3.  Two of the most common types of 
reactions in polyketide metabolism are the hydroxylation of hydrocarbons and the 
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epoxidation of alkenes (Bernhardt 2006).  The hydroxylation of hydrocarbons are more 
commonly seen in polyketide synthesis and will be a major focus of this work. 
 
 
 
TABLE I.3. Possible cytochrome P450 reactions (Bernhardt 2006) 
 
 
Hydrocarbon hydroxylation 
S-Oxidation 
Oxidative deamination 
Oxidative dehalogenation 
Aldehyde and Alcohol oxidations 
Dehydrogenation 
Dehydrations 
Reductive dehalogenations 
N-Oxide reduction 
Epoxide reduction 
Reductive β-scission of alkyl peroxides 
Isomerizations 
Alkene epoxidation 
Alkyne oxygenation 
Arene epoxidation 
Aromatic hydroxylation 
N-Dealkylation 
S-Dealkylation 
O-Dealkylation 
N-Hydroxylation 
N-Oxidation 
NO reductions 
Oxidative C-C bond cleavage 
 
 
 
The diversity of polyketides is attributed to the diverse architectural variety of 
polyketide synthases (PKS).  Following the biosynthesis of a polyketide core by the PKS, 
the products are modified by other enzymes, in which the compound undergoes various 
types of reactions, such as oxidation, methylation, and acylation (Lee 2004).  The 
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oxidation of polyketides is often done through hydroxylations at aliphatic centers by 
cytochrome P450 monooxygenases.  A good example of P450s involved in polyketide 
biosynthesis is the erythromycin C-12 hydroxylase, EryK, shown in figure I.15 (Lee 
2004).   
 
 
FIGURE I.15.  The involvement of EryK in the biosynthesis of erythromycin A (Lee 
2004)  
 
 
 
 
 
This pathway represents an important role that P450s play in the biosynthesis of 
polyketides.  As many cytochrome P450s do, EryK is able to catalyze the hydroxylation 
of a specific aliphatic site on the natural product.  As seen in figure I.15, EryK is able to 
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catalyze the hydroxylation of Erythromycin B, but the preferred pathway is the 
hydroxylation of Erythromycin D to Erythromycin C (Lee 2004).   
Another polyketide hydroxylase, PikC, is also a well known cytochrome P450.  
This hydroxylase has the ability to catalyze the hydroxylation of two structurally different 
substrates, YC-17 and narbomycin.  The flexibility that PicK shows during the 
hydroxylation of the substrates has been useful for the construction of novel macrolides 
and ketolides (Lee 2004).  Figure I.16 shows that PicK can hydroxylate narbomycin 
through C-12 hydroxylation to form pikromycin.  PicK is also able to catalyze the 
hydroxylation of either C-10 or C-12 YC-17 to form methymycin and neomethymycin, 
respectively (Lee 2004).   
 
 
FIGURE I.16. Hydroxylation of YC-17 and Narbomycin by PicK (Lee 2004) 
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The diversity of polyketides is attributed to the structural organization of 
polyketide synthases, and tailoring reactions, which occur after the synthases complete 
the polyketide.  The polyketide synthases assemble polyketides by a similar mechamisn 
as fatty acid synthesis.  This homology is important when trying to determine the 
pathway each synthase undergoes.  Following polyketide synthesis, the polyketides are 
often further modified by other tailoring enzymes.  Cytochrome P450s are a common 
type of tailoring enzyme that are responsible for the hydroxylation of many polyketides.  
We believe that PksS is a cytochrome P450 and will hydroxylate dihydrobacillaene, 
bacillaene, or both.  The following two chapters outline our work towards the purification 
and characterization of this protein. 
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CHAPTER II  
CLONING, OVEREXPRESSION, AND PURIFICATION OF PKSS 
II. A.  Production of pQE60/pksS 
II.A.1. Goals  
In order to determine the function of PksS in bacillaene biosynthesis, pksS must 
first be cloned into a vector suitable for the efficient overexpression of PksS. The vector 
pQE60 was chosen for its known effectiveness in directing protein synthesis and for 
incorporating His-Tag sequences into recombinant proteins. This vector controls protein 
overexpression by using an optimized T5 promoter(Gu 1994; Flachmann 1996; Noji 
1997; Greiner 1998).  The T5 promoter is also controlled by the LacI repressor, which is 
supplied in trans by another plasmid called pREP4.  The LacI repressor is a well-
documented means to rationally control the transcription of the gene through the addition 
of isopropyl-β-D-thiogalactoside, an artificial inducer (Gu 1994; Flachmann 1996; Noji 
1997; Greiner 1998).  The cloning of pksS into the pQE60 vector is accomplished by 
utilizing the restriction sites, NcoI and BglII, located in the vector and incorporated into 
the insert through PCR primers.  Following the digests, the target gene and vector are 
connected by T4 ligase.  The T4 ligase catalyses the formation of a phosphodiester bond 
between a 5’ phosphate group and a 3’ hydroxyl group (Engler 1982 ; Remaut 1983; 
Sambrook 1989).   
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The ligation products are obtained by transforming the crude reaction into 
competent E. coli and grown under antibiotic selection. The gene of interest can then be 
overexpressed by induction with IPTG to produce the target protein, PksS.  After the 
successful production of PksS, a C-terminal His  tag, which is incorporated into the 
protein by the cloning vector, will be used for affinity purification.  When combined with 
a nickel-nitrilotriacetic acid (Ni-NTA) column, the imidazole side chains in the protein’s 
His-tag is expected to form a complex with the Ni , (Figure II.1) ultimately allowing for 
the removal of other proteins and impurities.  The Ni-NTA column occupies four of the 
six binding sites of the nickel, leaving two that can be occupied by adjacent imidazoles 
on a protein (Anderson 1997; Lebrón 1998 ; West 2000).  After several washes of 
increasingly higher concentrations of imidazole, the protein is eventually eluted from the 
column.  
6
+2
FIGURE II.1.  Ni-NTA column purification of His-Tagged proteins (Anderson 1997; 
Lebrón 1998 ; West 2000) 
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II.B. Results  
II.B. 1. Preliminary data of cloning pksS  
In prior work, Dr. Jason Reddick and Dr. Gregory Raner attempted to clone pksS 
using two different sets of primers, Set 1 and Set 2.  The primers used during each 
polymerase chain reaction throughout this research are reported in Table II.1.  Upon 
completion of PCR, electrophoresis showed that the primers were designed correctly so 
they continued to clone pksS with this PCR product.  After purification of the PCR 
product, they proceeded to ligate the insert into the plasmid, pET-28a.  After several 
unsuccessful attempts to express the protein they decided to try new primers.   
II.B.2.  Cloning pksS with vent polymerase  
In an attempt to clone pksS, several primers were designed incorporating NcoI and 
BglII restriction sites at the ends.  These primers were combined with Vent polymerase, a 
polymerase with 3’—5’ proofreading exonuclease activity, and the genomic DNA from 
Bacillus subtilis 168, as a template (de Noronha 1992).   
Through PCR, pksS was amplified from Bacillus subtilis strain 168 genomic 
DNA.  The gel electrophoresis showed an intense band between 1100-1200 bp, 
demonstrating a successful PCR.  Upon completion, pksS was purified and prepared for 
the restriction digest/ligation step utilizing the NcoI and BglII restriction sites.   
An agarose gel showed that the restriction digest was successful, therefore, the 
pksS insert and pQE60 plasmid, shown in figure II.2, were ligated using T4 ligase.  In 
three separate reactions, different concentrations of insert were used to ensure that 
optimal ligation conditions were approached.   
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FIGURE II.2.  pQE60 vector map showing restriction site locations (Anderson 1997; 
Lebrón 1998 ; West 2000) 
 
 
 
 
Following the ligation, the mixture was transformed into competent DH5α (E. 
coli) cells.  Once the plasmids were transformed into the host cell, the cells were plated 
on agar plates containing ampicillin.  Cells containing 2 μL and 5 μL volumes grew after 
a 24 hour incubation period.  Plasmids from the four starter cultures were inoculated with 
cells and were grown overnight at 37 ºC with kanamycin and ampicillin.  The four 
cultures were then purified the following day.   
Following the purification, the plasmids were screened using Taq (HotMaster) 
polymerase because sequence fidelity was not required.  Following the PCR, a gel was 
run to determine if pksS had been successfully cloned into the pQE60 plasmid.  The 
agarose gel showed a band of approximately 4 kb, which is 3 kb longer than the desired 
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gene.  Unsure of the cause of this increase, a restriction digest was run on the purified 
plasmid DNA to determine the sizes of the gene.  The digest showed several bands of 
incorrect sizes.  Therefore, the ligation was deemed unsuccessful. 
After the failure of the previous experiments, the cloning process was restarted 
from PCR using the upstream primers pksS pQEUP3 and pksS pQEUP4, shown in Table 
II.1, and the downstream primer pksS.  The agarose gel used to determine if the gene was 
amplified showed one band for pksS pQEUP3 at the correct size, 1.12 kb, and three 
bands for pksS pQEUP4.  PCR was reattempted several times for pQEUP4 to the same 
effect.  At this point, it was determined that the upstream primer pksS pQEUP3, was 
effective and pksS pQEUP4 was not effective for PCR.     
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TABLE II.1. List of primers used in PCR 
 
Designated Name Sequence 5’—3’ 
Set 1 UP 5'- TACCCTATTAGGCGGCTAGCATGCAAATGGA -3'  
Set 1 DN 5'- TCATCAGGTGCAACCTCGAGTTCAATATCAGGAAAT - 3'  
Set 2 UP 5'- GCAATTTGATTCATCTATTTACCCTATTAGGCGGCTAGC -3' 
Set 2 DN 5'- CTCCATTGAATGTCATCAGGTGCAACCTCGAG -3' 
pksS pQE-UP1 5' - TATCCATGGAAATGGAAAAATTG - 3' 
pksS pQE-UP2 5' - ATGCCCATGGAAAAATTGATG - 3' 
pksS pQE-DN 5' - TATAGATCTGGAAATCTCTTCAAAACG - 3' 
pksS pQEUP3 5' - TATCCATGGAAATGGAAAAATTGATGTTTCATCCG - 3' 
pksS pQEUP4 5' - ATGCCCATGGAAAAATTGATGTTTCATCCGCATGG - 3' 
pksS pQEDN2 5' - TATAGATCTGGAAATCTCTTCAAAAGCTGC - 3' 
pksS UP SAA 5' - CGAGGACCATGGAAATGGAAAAATTG - 3' 
pksS DN2 SAA 5' - CAAGTTCTAGATCTGGAAATCTCTTCAAAAGC - 3' 
pksS long DN SAA 5' - GGGGCGTTTTGAAGATCTTTTTGAAAGTGAAACAGG - 3' 
 
II.B.3. Topo cloning  
In another attempt to clone pksS, a PCR was run using the upstream primer pksS 
pQEUP3 and the downstream primer pksS pQEDN2.   The product was purified and then 
cloned into pBAD using topoisomerase cloning technology.  After ligating the pksS into 
the pBAD vector, the plasmid was transformed into “One Shot Top10 Competent Cells,” 
plated onto an ampicillin/LB plate, and grown overnight at 37 ºC.  Three colonies from 
two plates were used to inoculate starter cultures containing ampicillin.  Following the 
incubation, the colonies were purified and were digested using the restriction sites NcoI 
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and BglII.  Following the restriction digest, gel electrophoresis revealed that the cloning 
of pksS was unsuccessful by the lack of bands.   
II.B.4.  Cloning pksS using Phusion polymerase  
In another attempt to successfully clone the pksS gene, a new polymerase, 
Phusion High-Fidelity DNA Polymerase, was used.  The PCR was run using the 
upstream primer pksS pQEUP3 and the downstream primer pksS pQEDN2.  After 
completion of the PCR, gel electrophoresis was used to determine if pksS was amplified.  
The gel revealed that the amplification of the gene was unsuccessful.  
 After the previous failure to clone pksS, a new upstream primer, pksS UP SAA 
and downstream primer, pksS DN SAA were designed.  Following gel electrophoresis, 
shown in figure II.3, the product was purified.  This PCR product and cloning vector, 
pQE60, were then digested with NcoI and BglII.  The digested material was ligated using 
three different concentration of insert as before.  After incubation, the ligation mixtures 
were transformed into a new host cell, M15[pREP4] and then plated onto agar plates 
containing ampicillin and kanamycin.  The following day, transformants were used to 
inoculate starter cultures, which were grown overnight.  The plasmids were purified from 
the starter cultures using the “QIAprep Spin Miniprep Kit.”  After purification, the 
plasmids were digested by NcoI/BglII and analyzed by agarose gel electrophoresis.  The 
gel revealed that the pksS gene was successfully cloned into pQE60. 
 
 
 
 
34 
 
 
FIGURE II.3.  Agarose gel of pksS pQE UPSAA and pksS pQE DN SAA 
 
 
 
 
 
 
After the successful cloning of pksS into pQE60, the plasmids were retransformed 
into M15[pREP4] and plated.  The next step was to overexpress pksS using the plasmid.  
The cells were grown in terrific broth (TB) media containing 30 μg/ml kanamycin and 25 
μg/ml ampicillin.  After a two day incubation period at room temperature, the cells were 
induced with 0.63 mM isopropyl-beta-D-thiogalactopyranoside (IPTG) (Phillips 1998).  
After induction, the culture continued to grow at room temperature with shaking at a 
speed of 70 rpm for 24 hours (Phillips 1998).  The cells were harvested by centrifuging 
the cultures and then stored at –80.0ºC.   
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Following the overexpression procedure, a Ni-NTA column was used to purify 
PksS.  During the chromatography, aliquots of the protein were collected from each step 
in the imidazole gradients.  The samples were analyzed by SDS-PAGE (Sodium Dodecyl 
Sulfate PolyAcrylamide Gel Electrophoresis) to check if the protein had been extracted.  
At this point, it was determined the pksS had not been expressed, due to the absense of a 
band with a molecular weight of 46 kDa in any gel sample.   
II.B.5.  Cloning, overexpression, purification with pLys RARE plasmid 
 It is quite possible that the protein is not being produced due to a presence in the 
pksS gene of codons that E. coli rarely uses.  In fact, there are 3 consecutive codons in the 
middle of the gene wich are rarely used in E. coli.  By coexpressing pQE60 and pksS with 
another plasmid, pLys RARE, it would be possible to express codons not normally used 
during overexpression.  The pLys RARE plasmid was transformed into M15[pREP4] 
already replicating pQE60/pksS, and then the cells were plated.  Following incubation, 
colonies were used to inoculate starter cultures.  Upon reaching optical density, 
OD595=0.50-0.60, the cultures were used to inoculate TB media.  After growing for two 
days, the cultures were induced with IPTG.  Samples were then removed every hour for 
five hours to check for cytochrome P450 expression using the carbon monoxide complex 
spectroscopy method (Phillips 1998).  The assays did not display peaks corresponding to 
a cytochrome P450, therefore, it was determined that there was no P450 present in the 
culture.   
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Following purification, SDS-PAGE was used to determine if any protein of ~46 
kDa was expressed during the growth.  Protein collected during purification revealed that 
PksS had not been produced.   
In another attempt to overexpress pksS, other transformants that tested positive for 
pksS, were used to inoculate several starter cultures.  Following incubation, the starter 
cultures were used to inoculate Luria-Bertani (LB) cultures.  After reaching optical 
density of 0.5-0.6 at 595 nm, the cultures were induced with IPTG and grown for three 
hours.   
Throughout the overexpression, samples were taken for SDS-PAGE analysis.  A 
faint band around the correct size was seen in some of the samples.  To increase the 
production of PksS, the media was prepared with 2% glycerol to enrich the culture.  The 
LB was inoculated using starter cultures containing colonies from a previous 
transformation and grown according to standard protocol.  Following incubation, samples 
were analyzed by SDS-PAGE.  No bands at 46 kDa were detected and a new method 
was chosen.   
 The next attempt to overexpress pksS utilized the introduction of 1% dextrose to 
the LB media.  Starter cultures were grown using colonies from the previous 
transformation and then used to inoculate the media.  Following induction of the media, 
samples were removed from the culture and analyzed by SDS-PAGE.  Also, Ni-NTA 
purification fractions obtained were analyzed by SDS-PAGE.  The gels resulted in 
inconclusive information and the procedure was repeated again.   
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 After several unsuccessful attempts to overexpress PksS, M15[pREP4] 
transformants containing pksS/pQE60 were plated and made competent using 50 mM 
CaCl2.  The pLys RARE plasmid was transformed into the cells and grown on an agar 
plate.  This transformation resulted in two different sizes of colonies, large and small.  
Both sizes of the colonies were used to inoculate starter cultures.  Following their 
incubation, the starter cultures were used to inoculate LB containing dextrose.  After 
inducing the media, samples were removed to determine by SDS-PAGE if PksS was 
being produced.  Although the results from the culture were inconclusive, crude extracts 
were subjected to Ni-NTA chromatography.  During the purification, samples were 
removed from the washes and then analyzed by SDS-PAGE.  The gel showed no 
conclusive evidence of His-Tagged pksS being expressed.   
II.B.6.  Sequencing pksS 
 Due to several unsuccessful attempts to clone and purify PksS, pQE60/pksS 
plasmid was sequenced by standard dye-termination DNA sequencing (SeqWright, Inc.).  
The sequence data indicated that our plasmid lacked Guanosine 1111 reported for 
pksS from the genomic sequence for Bacillus subtilis.  The published sequence and our 
experimental sequence of pksS is shown in figure II.4.  The location of the missing 
nucleotide is highlighted.  
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FIGURE II.4. Alignment of published sequence of pksS to data reported from sequencing 
Published pksS   1    atgcaaatggaaaaattgatgtttcatccgcatggtaaagagtttcatcacaatcctttt 60    
Seq pksS insert  1    atgcaaatggaaaaattgatgtttcatccgcatggtaaagagtttcatcacaatcctttt 60    
 
Published pksS   61   tcagttttaggacgatttagagaggaagagcccattcaccgatttgaattaaaacggttc 120   
Seq pksS insert  61   tcagttttaggacgatttagagaggaagagcccattcaccgatttgaattaaaacggttc 120   
 
Published pksS   121  ggagccacatatccggcctggttaattacccgatacgatgattgtatggcctttttaaaa 180   
Seq pksS insert  121  ggagccacatatccggcctggttaattacccgatacgatgattgtatggcctttttaaaa 180   
 
Published pksS   181  gacaatcgaattacaagagacgtaaaaaatgtgatgaaccaagaacaaatcaaaatgctc 240   
Seq pksS insert  181  gacaatcgaattacaagagacgtaaaaaatgtgatgaaccaagaacaaatcaaaatgctc 240   
 
Published pksS   241  aacgttagtgaagatatcgattttgtatccgatcatatgctggcaaaagacacacctgac 300   
Seq pksS insert  241  aacgttagtgaagatatcgattttgtatccgatcatatgctggcaaaagacacacctgac 300   
 
Published pksS   301  catacccgcctgagatcacttgttcatcaagcatttactccccgaaccattgaaaatctg 360   
Seq pksS insert  301  catacccgcctgagatcacttgttcatcaagcatttactccccgaaccattgaaaatctg 360   
 
Published pksS   361  cgcggcagcattgaacaaattgctgaacagcttttagatgaaatggaaaaagaaaataaa 420   
Seq pksS insert  361  cgcggcagcattgaacaaattgctgaacagcttttagatgaaatggaaaaagaaaataaa 420   
 
Published pksS   421  gcggatatcatgaaatccttcgcttcccctttgccttttattgttatatctgaattgatg 480   
Seq pksS insert  421  gcggatatcatgaaatccttcgcttcccctttgccttttattgttatatctgaattgatg 480   
 
Published pksS   481  ggaatcccaaaagaagatcggtcacagtttcaaatctggaccaatgcgatggttgatacc 540   
Seq pksS insert  481  ggaatcccaaaagaagatcggtcacagtttcaaatctggaccaatgcgatggttgatacc 540   
 
Published pksS   541  tctgaaggtaatagagagctgacaaatcaggcccttcgtgaatttaaagattatatcgct 600   
Seq pksS insert  541  tctgaaggtaatagagagctgacaaatcaggcccttcgtgaatttaaagattatatcgct 600   
 
Published pksS   601  aagctgatccatgacagaagaataaagccaaaagacgatttaatcagcaaacttgtgcat 660   
Seq pksS insert  601  aagctgatccatgacagaagaataaagccaaaagacgatttaatcagcaaacttgtgcat 660   
 
Published pksS   661  gctgaggaaaacggcagcaagttaagcgaaaaagagctctattcgatgctgttcttgctc 720   
Seq pksS insert  661  gctgaggaaaacggcagcaagttaagcgaaaaagagctctattcgatgctgttcttgctc 720   
 
Published pksS   721  gttgtagccggccttgaaacaactgttaacttactcggctcaggcaccctcgcattgctg 780   
Seq pksS insert  721  gttgtagccggccttgaaacaactgttaacttactcggctcaggcaccctcgcattgctg 780   
 
Published pksS   781  cagcacaagaaggaatgtgagaagctcaagcagcagcctgaaatgatcgctacagcggtt 840   
Seq pksS insert  781  cagcacaagaaggaatgtgagaagctcaagcagcagcctgaaatgatcgctacagcggtt 840   
 
Published pksS   841  gaagaattgctgcgatacacctcacctgtcgttatgatggcaaatcggtgggccatcgaa 900   
Seq pksS insert  841  gaagaattgctgcgatacacctcacctgtcgttatgatggcaaatcggtgggccatcgaa 900   
 
Published pksS   901  gactttacatataaggggcattcgatcaaaagaggagacatgatttttataggcatcgga 960   
Seq pksS insert  901  gactttacatataaggggcattcgatcaaaagaggagacatgatttttataggcatcgga 960   
 
Published pksS   961  tctgccaatcgcgacccgaatttttttgagaaccccgaaatattaaatataaatcggtcg 1020  
Seq pksS insert  961  tctgccaatcgcgacccgaatttttttgagaaccccgaaatattaaatataaatcggtcg 1020  
 
Published pksS   1021 cctaatagacatatttcttttggttttggcattcatttctgcttaggagcgcctcttgcc 1080  
Seq pksS insert  1021 cctaatagacatatttcttttggttttggcattcatttctgcttaggagcgcctcttgcc 1080  
 
Published pksS   1081 aggctggaaggccacattgcatttaaagcagcttttgaagagatttcc------------ 1128  
Seq pksS insert  1081 aggctggaaggccacattgcatttaaagca-cttttgaagagatttcc------------ 1128  
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II.B.7. Using new primers, PKSS UP SAA and PKSS DN2 SAA  
Due to the high adenine/thiamine content in the our downstream primer, it is 
possible that the primers may have incorrectly annealed and the guanosine was skipped 
during PCR.  After receiving the sequencing information, new primers, pksS UP SAA 
and pksS DN2 SAA, were designed that would force the PCR to include G1111, if it was 
present.  Briefly, the downstream primer had the complementary cytosine at the 3’ end, 
and the PCR should work only if G1111 was present.  After determining that the PCR 
yielded the correct sized product by gel electrophoresis, also shown in figure II.5, the 
product was purified and digested for cloning into pQE60.   
FIGURE II.5. Agarose gel of PCR product using pksS UP SAA and pksS DN2 SAA 
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The restriction digest products, shown in figure II.6, were then ligated together 
using three different concentrations of insert.  The ligation mixtures were transformed 
into M15[pREP4] cells and plated on agar plates.  The resultant colonies were used to 
inoculate several starter cultures.  Each culture was purified and then digested to verify 
the addition of the insert into the plasmid, shown in figure II.6.  After revealing 
successful ligation products, a successful plasmid was retransformed into M15[pREP4] .  
For the purpose of sequencing and overexpression, the same colony was used to inoculate 
two starter cultures comprised of LB and dextrose.  Following the incubation, the plasmid 
from one starter culture was purified and sequenced.  The second culture was used to 
inoculate an overexpression culture.  The culture was grown to optimal density and 
induced with IPTG.  Subsequently, samples to be analyzed by SDS-PAGE were removed 
during the overexpression period and purification process. The gel revealed that no PksS 
protein was being produced at any point.   
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FIGURE II.6.  Restriction digest of pksS and pQE60, Lane 1: Molecular Weight, Lane 3: 
Uncut pQE60, Lane 5: Cut pQE60, Lane 7: Cut pksS 
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FIGURE II.7. Restriction digest of ligation reactions, Lane 1: Molecular Weight, Lane 
3,4:  2 μL insert: 1 μL plasmid, Lane 5,6: 5 μL insert: 1 μL plasmid, Lane 7,8: 10 
μL insert: 1 μL of plasmid 
 
 
 
 
  
Despite using primers that would force the PCR reaction to include G1111, 
sequencing still revealed an absence of G1111.  The best explanation for this is that the 
guanosine 1111 previously reported in the Bacillus subtilis sequence was a mistake.  The 
polymerase used during our PCR, Phusion, is a proofreading polymerase, therefore it 
likely cut the theoretical G1111 complement cytosine, allowing the polymerase to 
continue DNA synthesis on the template.  These results suggest that the published 
genome sequence for BS168 has an erroneous extra guanosine after A1110.  Such an 
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error is a frame-shift error, therefore, the assigned stop codon is incorrect.  The genomic 
database was searched for the next in frame stop codon, and we determined that the 
true length of pksS was 1224 bp instead of 1128 bp, shown in figure II.8.  The 
corrected amino acid sequence, which will be used for sequence homology is shown in 
figure II.9. 
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FIGURE II.8.  Corrected sequence of pksS  
pksS corrected   1    atgcaaatggaaaaattgatgtttcatccgcatggtaaagagtttcatcacaatcctttt 60    
published pksS   1    atgcaaatggaaaaattgatgtttcatccgcatggtaaagagtttcatcacaatcctttt 60    
 
pksS corrected   61   tcagttttaggacgatttagagaggaagagcccattcaccgatttgaattaaaacggttc 120   
published pksS   61   tcagttttaggacgatttagagaggaagagcccattcaccgatttgaattaaaacggttc 120   
 
pksS corrected   121  ggagccacatatccggcctggttaattacccgatacgatgattgtatggcctttttaaaa 180   
published pksS   121  ggagccacatatccggcctggttaattacccgatacgatgattgtatggcctttttaaaa 180   
 
pksS corrected   181  gacaatcgaattacaagagacgtaaaaaatgtgatgaaccaagaacaaatcaaaatgctc 240   
published pksS   181  gacaatcgaattacaagagacgtaaaaaatgtgatgaaccaagaacaaatcaaaatgctc 240   
 
pksS corrected   241  aacgttagtgaagatatcgattttgtatccgatcatatgctggcaaaagacacacctgac 300   
published pksS   241  aacgttagtgaagatatcgattttgtatccgatcatatgctggcaaaagacacacctgac 300   
 
pksS corrected   301  catacccgcctgagatcacttgttcatcaagcatttactccccgaaccattgaaaatctg 360   
published pksS   301  catacccgcctgagatcacttgttcatcaagcatttactccccgaaccattgaaaatctg 360   
 
pksS corrected   361  cgcggcagcattgaacaaattgctgaacagcttttagatgaaatggaaaaagaaaataaa 420   
published pksS   361  cgcggcagcattgaacaaattgctgaacagcttttagatgaaatggaaaaagaaaataaa 420   
 
pksS corrected   421  gcggatatcatgaaatccttcgcttcccctttgccttttattgttatatctgaattgatg 480   
published pksS   421  gcggatatcatgaaatccttcgcttcccctttgccttttattgttatatctgaattgatg 480   
 
pksS corrected   481  ggaatcccaaaagaagatcggtcacagtttcaaatctggaccaatgcgatggttgatacc 540   
published pksS   481  ggaatcccaaaagaagatcggtcacagtttcaaatctggaccaatgcgatggttgatacc 540   
 
pksS corrected   541  tctgaaggtaatagagagctgacaaatcaggcccttcgtgaatttaaagattatatcgct 600   
published pksS   541  tctgaaggtaatagagagctgacaaatcaggcccttcgtgaatttaaagattatatcgct 600   
 
pksS corrected   601  aagctgatccatgacagaagaataaagccaaaagacgatttaatcagcaaacttgtgcat 660   
published pksS   601  aagctgatccatgacagaagaataaagccaaaagacgatttaatcagcaaacttgtgcat 660   
 
pksS corrected   661  gctgaggaaaacggcagcaagttaagcgaaaaagagctctattcgatgctgttcttgctc 720   
published pksS   661  gctgaggaaaacggcagcaagttaagcgaaaaagagctctattcgatgctgttcttgctc 720   
 
pksS corrected   721  gttgtagccggccttgaaacaactgttaacttactcggctcaggcaccctcgcattgctg 780   
published pksS   721  gttgtagccggccttgaaacaactgttaacttactcggctcaggcaccctcgcattgctg 780   
 
pksS corrected   781  cagcacaagaaggaatgtgagaagctcaagcagcagcctgaaatgatcgctacagcggtt 840   
published pksS   781  cagcacaagaaggaatgtgagaagctcaagcagcagcctgaaatgatcgctacagcggtt 840   
 
pksS corrected   841  gaagaattgctgcgatacacctcacctgtcgttatgatggcaaatcggtgggccatcgaa 900   
published pksS   841  gaagaattgctgcgatacacctcacctgtcgttatgatggcaaatcggtgggccatcgaa 900   
 
pksS corrected   901  gactttacatataaggggcattcgatcaaaagaggagacatgatttttataggcatcgga 960   
published pksS   901  gactttacatataaggggcattcgatcaaaagaggagacatgatttttataggcatcgga 960   
 
pksS corrected   961  tctgccaatcgcgacccgaatttttttgagaaccccgaaatattaaatataaatcggtcg 1020  
published pksS   961  tctgccaatcgcgacccgaatttttttgagaaccccgaaatattaaatataaatcggtcg 1020  
 
pksS corrected   1021 cctaatagacatatttcttttggttttggcattcatttctgcttaggagcgcctcttgcc 1080  
published pksS   1021 cctaatagacatatttcttttggttttggcattcatttctgcttaggagcgcctcttgcc 1080  
 
pksS corrected   1081 aggctggaaggccacattgcatttaaagca-cttttgaagagatttcctgatattgaact 1139  
published pksS   1081 aggctggaaggccacattgcatttaaagcagcttttgaagagatttcc------------ 1128  
 
pksS corrected   1140 tgcggttgcacctgatgacattcaatggagaaaaaatgtctttttaagaggattagaaag 1199  
published pksS   1128 ------------------------------------------------------------ 1128  
 
pksS corrected   1200 tctccctgtttcactttcaaaataa 1224  
published pksS   1128 ------------------------- 1128  
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FIGURE II.9.  Corrected amino acid sequence for experimental pksS 
 
pksS corrected aa  1   MQMEKLMFHPHGKEFHHNPFSVLGRFREEEPIHRFELKRF 40   
pksS published aa  1   MQMEKLMFHPHGKEFHHNPFSVLGRFREEEPIHRFELKRF 40   
 
pksS corrected aa  41  GATYPAWLITRYDDCMAFLKDNRITRDVKNVMNQEQIKML 80   
pksS published aa  41  GATYPAWLITRYDDCMAFLKDNRITRDVKNVMNQEQIKML 80   
 
pksS corrected aa  81  NVSEDIDFVSDHMLAKDTPDHTRLRSLVHQAFTPRTIENL 120  
pksS published aa  81  NVSEDIDFVSDHMLAKDTPDHTRLRSLVHQAFTPRTIENL 120  
 
pksS corrected aa  121 RGSIEQIAEQLLDEMEKENKADIMKSFASPLPFIVISELM 160  
pksS published aa  121 RGSIEQIAEQLLDEMEKENKADIMKSFASPLPFIVISELM 160  
 
pksS corrected aa  161 GIPKEDRSQFQIWTNAMVDTSEGNRELTNQALREFKDYIA 200  
pksS published aa  161 GIPKEDRSQFQIWTNAMVDTSEGNRELTNQALREFKDYIA 200  
 
pksS corrected aa  201 KLIHDRRIKPKDDLISKLVHAEENGSKLSEKELYSMLFLL 240  
pksS published aa  201 KLIHDRRIKPKDDLISKLVHAEENGSKLSEKELYSMLFLL 240  
 
pksS corrected aa  241 VVAGLETTVNLLGSGTLALLQHKKECEKLKQQPEMIATAV 280  
pksS published aa  241 VVAGLETTVNLLGSGTLALLQHKKECEKLKQQPEMIATAV 280  
 
pksS corrected aa  281 EELLRYTSPVVMMANRWAIEDFTYKGHSIKRGDMIFIGIG 320  
pksS published aa  281 EELLRYTSPVVMMANRWAIEDFTYKGHSIKRGDMIFIGIG 320  
 
pksS corrected aa  321 SANRDPNFFENPEILNINRSPNRHISFGFGIHFCLGAPLA 360  
pksS published aa  321 SANRDPNFFENPEILNINRSPNRHISFGFGIHFCLGAPLA 360  
 
pksS corrected aa  361 RLEGHIAFKALLKRFPDIELAVAPDDIQWRKNVFLRGLES 400  
pksS published aa  361 RLEGHIAFKAAFEEIS--~~~~~~~~~~~~~~~~~~~~~~ 376  
 
pksS corrected aa  401 LPVSLSK*                                 408  
pksS published aa  376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376  
 
 
 
II.B.8. Using a new downstream primer, PKSS LONG DN SAA 
A new downstream primer pksS long DN SAA, which would include the new 
stretch of sequence at the 3’ end, was combined with the upstream primer pksS UP SAA 
for a PCR.  The product was checked using gel electrophoresis, shown in figure II.10 and 
then purified using the “QIAquick PCR Purification Kit.”  After purification the gene 
underwent a restriction digest, shown in figure II.11, and ligation reaction with pQE60.  
Three different concentrations of the insert were used to ensure successful ligation into 
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the vector.  Each ligation reaction was then transformed into competent M15[pREP4] 
cells and plated onto agar plates in preparation for sequencing.  Transformants were 
screened for insert as before and one positive clone was sequenced as before.  According 
to the sequencing results, pksS was successfully cloned into the pQE60 plasmid, and all 
expected nucleotides minus the abberant G1111, shown in Figure II.8, were present in 
the correct sequence.   
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FIGURE II.10. Agarose gel of PCR products using pksS UP SAA and pksS long DN 
SAA 
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FIGURE II.11.  Restriction digest of pksS and pQE60, Lane 1: Molecular Weight, Lane 
3: Uncut pQE60, Lane 5: Cut pQE60, Lane 7: Cut pksS 
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II.B.9.  Overexpression and purification of PksS  
Following the successful cloning of pksS into pQE60, another transformant was 
used to inoculate a starter culture containing LB and dextrose.  Following inoculation of 
the LB media, the cultures were induced with IPTG.  The cells were then harvested and 
purified using a Ni-NTA column.  Samples of the washes were collected and run through 
a SDS-PAGE gel.  Figure II.12 shows the SDS-PAGE for the crude extract of pksS and 
the purified protein of pksS.  A SDS-PAGE molecular marker was used to determine the 
approximate size of the purified pksS.  Due to the 1 M imidazole within the elution 
buffer, which could interfere with subsequent spectroscopy, the protein was subjected to 
Sephedex G25 gel filtration to exchange the buffer.  After the protein was added to the 
column, it was eluted using 50 mM potassium phosphate buffer at pH of 8.00.   
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FIGURE II.12. SDS-PAGE Gel of purified PksS 
 
 
 
 
II.D. CONCLUSION  
 
 
 
97.4 KDa 
66.2 KDa 
45.0 KDa 
31.0 KDa 
21.5 KDa 
~47.0 
KDa 
Crude Extract PksS protein SDS-PAGE Molecular Weight Marker 
 
 
 
II.B.10 Sequence Homology 
 In an attempt to asses the importance of the newly annotated amino acid 
sequence in the structure of PksS, the corrected amino acid sequence was loaded into the 
Basic Local Alignment Sequencing Tool (BLAST), tool supplied by the National Center 
for Biotechnology Information.  After performing “Protein-protein BLAST” with the 
sequences, the long list of similar candidates confirmed that PksS was likely a P450.  The 
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sequence was aligned with the published sequence of PikC from Streptomyces venezuelae 
(Sherman 2006).  The following 3D figure, obtained from the Swiss-modeling program, 
Deep View, shows a theoretical protein structure of PksS, built by homology with PikC.  
Figure II.13 shows that the additional sequence at the C-terminus is likely important to 
the overall protein structure.  To highlight the importance of the additional sequence, 
figure II.14 was generated.  The sequence that was not reported originally is colored 
lighter than the original sequence.  A lack of this C-terminal sequence is expected to 
cause protein misfolding.  With the completed structure, PksS is able to operate as a 
cytochrome P450.  The heme has also been included in the structure to illustrate the 
location of the heme within the active site.   
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FIGURE II.13  PksS homology using PikC 
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FIGURE II.14 Corrected sequence of PksS with unreported sequence highlighted in pink 
 
II.C. Conclusion  
 After several attempts to clone pksS into pQE60 using the published sequence of 
pksS by the genomic database, it was determined there was an error within the sequence.  
Through several cloning and sequencing experiments, the error was identified as an 
artificial insertion within the reported sequence of pksS of a guanosine at the 1111th 
position.  After correcting this error and searching the database for the next in-frame stop 
codon, pksS was determined to be 1224 base pairs long.  Following this correction, 
primers were redesigned reflecting this frame shift and PCR was repeated.  The product 
was then successfully ligated into the cloning vector using T4 ligase.  This process 
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resulted in the successful cloning of pksS into the cloning vector pQE60.   pksS/pQE60 
was then overexpressed using the host cell M15[pREP4] in LB containing a 1% solution 
of dextrose.  Following induction by IPTG, PksS was purified using a Ni-NTA column 
by utilizing the 6x His-Tag found at the C-terminus within the pQE60 cloning vector.  
The protein was eluted from the column elution buffer containing 1 M imidazole and then 
purified further using a Sephadex 25 column suspended in 50 mM potassium phosphate 
buffer, pH 8.0.  The Sephadex column was used instead of dialysis for removal of the 
imidazole.  Following the purification of PksS, the amino acid sequence was used to 
determine the function of PksS.  Using homology to other cytochrome P450s, PksS was 
identified as a cytochrome P450.  
II.D. Experimental  
II.D.1 Cloning and overexpression of pksS  
Initial attempts to clone pksS were unsuccessful because of primer errors.  To 
increase the chances of successful amplification of pksS, two different upstream primers 
were designed with the following sequences, pksS UP1, 5' - 
TATCCATGGAAATGGAAAAATTG - 3' (restriction site for NcoI) and pksS UP2, 5' - 
ATGCCCATGGAAAAATTGATG – 3' (restriction site for NcoI).  The downstream 
primer, pksS DN 2, 5' - TATAGATCTGGAAATCTCTTCAAAACG - 3' (restriction site 
for BglII) was used in both cases.  The upstream primers were combined separately with 
the downstream primer, the genomic DNA template, purified from Bacillus subtilis 168, 
dNTP’s, and Vent polymerase.   The PCR was run at the following conditions: 94.0ºC for 
two minutes; 30 cycles of 30 seconds at 98.0ºC, 30 seconds at 60.0ºC, and 90 seconds at 
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72.0ºC; then a hold at 4.0ºC.  After PCR trials, it was determined that the primers were 
not annealing correctly to the template.  At this point, new primers were designed, pksS 
pQEUP3, 5' - TATCCATGGAAATGGAAAAATTGATGTTTCATCCG - 3' (restriction 
site for NcoI) and pksS pQEUP4, 5' - 
ATGCCCATGGAAAAATTGATGTTTCATCCGCATGG - 3' (restriction site for NcoI). 
Vent polymerase was utilized with the upstream primer, pksS UP4, under the 
following conditions: 94.0ºC for two minutes; 30 cycles of 30 seconds at 98.0ºC, 30 
seconds at 50.0ºC, and 90 seconds at 72.0ºC; then a hold at 4.0ºC. Due to differences in 
the sequences of the upstream primers, pksS UP3, was subjected to the following 
conditions: 94.0ºC for two minutes; 30 cycles of 30 seconds at 98.0ºC, 30 seconds at 
45.0ºC, and 90 seconds at 72.0ºC; then a hold at 4.0ºC. After the formation of the PCR 
product, the samples were purified using the QIAquick PCR Purification Kit.  The PCR 
product and pQE60 plasmid were then digested separately with the restriction enzymes 
NcoI and BglII for 3.5 hours at 37.0ºC.  To inactivate the enzymes, the samples were then 
placed in a 65.0ºC water bath for 20 minutes. 
After incubation, a 0.7% low melting agarose gel was used to purify and measure 
the size of the material.  The bands were excised from the gel and incubated in a water 
bath at 75ºC.  The products were then combined at three different concentrations 
described here:  The insert:plasmid ratio for the 1st reaction was 2μL:1μL, for the second 
reaction 5μL:1μL, and for the 3rd reaction 1μL:2μL.  Each reaction was mixed with water, 
Ligase buffer, and T4 DNA ligase.  The samples were placed in a thermocycler overnight 
with the following conditions: 30 minutes at 37.0ºC, 2 hours at 23.0ºC, and then 4.0ºC for 
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the remainder of the incubation.  The following day, each mixture was transformed into 
competent DH5α (E. coli) cells by combining 20μL of the ligation mixture to 100μL of 
the chemically competent cells.  After a cold and heat shock, the cells were suspended in 
1 ml of LB and incubated at 37.0ºC for 1 hour.  Following the incubation, the cells were 
plated on agar plates with a final concentration of 25 mg/ml of ampicillin and 30 mg/ml 
of kanamycin and incubated overnight at 37.0ºC.  
The DH5α cells were made chemically competent by resuspending the cells in 3 
ml of CaCl2.  After a 30 minute incubation, the cells were resuspended again in 1 ml of 
CaCl2.  Colonies from each reaction plate were used to inoculate starter cultures 
containing LB and 25 mg/ml of ampicillin and 30 mg/ml of kanamycin.    The cultures 
were then incubated overnight at 37.0ºC and purified using a QIAprep Spin Miniprep Kit 
in which the protocol Plasmid DNA Purification Using the QIAprep Spin Miniprep Kit 
and a Microcentrifuge was followed.   
The plasmids were screened using PCR, in which Taq (HotMaster) polymerase 
was employed, and a restriction digest.  Both reactions showed incorrect band sizes, 
therefore, the ligation was deemed unsuccessful.   
II.D.2 Topo Cloning  
Cloning was restarted from PCR using the primers and conditions as before.  The 
polymerization resulted in an accurate sized band for the primers pksS UP3 and pksS DN 
2 and an absence of bands for the primers pksS UP4 and pksS DN2.  The process was 
repeated again for precautionary measures.  The results were reproduced and it was 
determined that the upstream primer pksS UP3 was not annealing correctly.   
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Following the PCR, the product obtained for the upstream primer pksS UP 3 and 
the downstream primer pksS DN2 was purified using the “QIAquick PCR Purification 
Kit.”  The next attempt to overexpress pksS into a new cloning vector, TOPO vector, 
required the “pBAD TOPO® TA Expression Kit.” Before the insert could be ligated into 
the vector, the product was combined with Taq polymerase, buffer, and dNTP’s and 
incubated in the thermocycler at 72ºC for 15 minutes.  This incubation period provides 
necessary 3’-deoxyadenosine overhangs to the insert to allow for correct ligation into the 
TOPO vector.   
The insert was ligated into the TOPO cloning vector by incubating the sample in a 
standard salt solution and vector for 15 minutes at room temperature.  Following the 
incubation, the plamids were transformed into “One Shot Top10 Competent Cells” by 
adding a small portion of a reaction into the competent cells.  The mixture was incubated 
for 30 minutes on ice, heat shocked for 30 seconds, and then LB was added.  The cells 
were shaken at 37ºC for 1 hour.  The cells were plated on agar plates containing 25 μg/ml 
of ampicillin and incubated overnight at 37.0ºC.  The following day, several starter 
cultures containing LB and 25 mg/ml of ampicillin were inoculated using colonies from 
the reaction plates.  The starter cultures were purified using the “Plasmid DNA 
Purification Using the QIAprep Spin Miniprep Kit and a Microcentrifuge” to prepare the 
plasmid for screening.  Gel electrophoresis showed that the cloning and ligation of pksS 
into the TOPO cloning vector was unsuccessful.   
In another attempt to successfully clone the pksS gene, a new polymerase, 
Phusion High-Fidelity DNA Polymerase, was used.  The PCR used the upstream primer 
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pksS UP3 and the downstream primer pksS DN2.  The conditions were the following: a 
30 second hold at 98.0ºC; 30 cycles of 10 seconds at 98.0ºC, 30 seconds at 59.0ºC, and 
30 seconds at 72.0ºC; then a hold of 5 minutes at 72.0ºC.  Gel electrophoresis showed no 
bands, therefore, the cloning was unsuccessful.  
II.D.3. Attempted cloning with new primers 
 The next attempt to clone pksS involved the fabrication of a new upstream primer, 
pksS UP SAA, 5' - CGAGGACCATGGAAATGGAAAAATTG - 3' (including a NcoI 
restriction site) and downstream primer, pksS DN SAA, 5' - 
CAAGTTCTAGATCTGGAAATCTCTTCAAAAGC - 3' (including a BglII restriction 
site) .  The PCR was conducted under the following conditions: a 30 second hold at 
98.0ºC; 30 cycles of 10 seconds at 98.0ºC, 30 seconds at 59.0ºC, and 30 seconds at 
72.0ºC; then a hold of 5 minutes at 72.0ºC.  Following PCR, the product was purified 
using the “QIAquick PCR Purification Kit.” The purified insert and pQE60 plasmid were 
digested for 3.5 hours at 37.0ºC using the appropriate restriction enzymes.  The enzymes 
were then heat inactivated by incubating the reactions in a 65.0ºC water bath for 20 
minutes.  Following the incubation, the digested material was purified by 0.7% low 
melting agarose gel.  Each band was removed for the gel and incubated in a water bath at 
75ºC to melt the agarose.  The products were then combined at three different 
concentrations described here:  The insert:plasmid ratio for the 1st reaction was 2μL:1μL, 
for the second reaction 5μL:1μL, and for the 3rd reaction 1μL:2μL.  Each reaction was 
mixed with water, Ligase buffer, and T4 DNA ligase.  The samples were placed in the 
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thermocycler overnight with the following conditions: 30 minutes at 37.0ºC, 2 hours at 
23.0ºC, and then 4.0ºC for the remainder of the incubation.  
The following day, each mixture was transformed into competent M15[pREP4] 
cells by combining 20μL of the ligation mixture to 100μL of the chemically competent 
cells.  After a 30 minute incubation on ice, the cells were heat shocked and then 
incubated at room temperature for 10 minutes.  One ml of LB was added to the 
transformation mixture and then incubated at 37.0ºC for 1 hour.  Following the 
incubation, the cells were plated on agar plates with a final concentration of 25 μg/ml of 
ampicillin and 30 μg/ml of kanamycin and then incubated overnight at 37.0ºC. Several 
starter cultures were inoculated using colonies from each concentration of the ligation 
mixtures and then purified using the “QIAprep Spin Miniprep Kit.”  The product was 
screened for insert acceptance using a restriction digest.  Gel electrophoresis show bands 
corresponding to the plasmid and insert.  It was concluded that the cloning of pksS was 
successful.   
Transformants from the previous reaction were then retransformed into host cell.  
A colony from each plate was used to inoculate starter cultures containing LB, 25 μg/ml 
of ampicillin, 30 μg/ml of kanamycin for the potential overexpression of PksS.  Each 
starter was used to inoculate a Terrific Broth (TB) overexpression culture containing 
2.4% Yeast, 1.2% Bacto Tryptone, 0.4% glycerol, 2.4% monobasic potassium phosphate, 
and 1.17% dibasic potassium phosphate.  The TB also contained 25 μg/ml of ampicillin 
and 30 μg/ml of kanamycin.  The overexpression culture was incubated for two days at 
200 rpm at room temperature and then induced with 0.63 mM isopropyl-β-D-
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thiogalactopyranoside (IPTG).  After induction, the culture continued to grow at room 
temperature with a speed of 70 rpm for 24 hours.  Following incubation, the cell cultures 
were centrifuged at 8,500 rpm at 4ºC for 30 minutes.  The pellet was stored at -80ºC.  
II.D.4.  Attempted purification of PksS protein 
The pellet from the previous step was resuspended in 20 ml of 1x Binding Buffer 
(5 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 7.9).  The protein was lysed 
using a Sonic Dismembrator for 3 minutes and then centrifuging for 30 minutes at 11,500 
rpm at 4ºC.  After syringe filtration, the protein was loaded on a 2 ml column bed of 
nickel-nitrilotriacetic acid (Ni-NTA) column.  Following the adsorption, the column was 
washed using 20 ml of the 1x Binding Buffer.  In the next wash, 12 ml of 1x Wash Buffer 
(60 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 7.9) were used. The protein was 
eluted from the column using 12 ml of 1x Eluent Buffer (1 M imidazole, 500 mM NaCl, 
20 mM Tris-HCl, pH 7.9).  During each wash, a 20 μL of the flow through was collected 
and combined with 80 μL SDS-PAGE buffer.  The samples were run in a 12% SDS-
PAGE to check if the protein had been extracted.  No bands were seen in the gel. 
II.D.5. Coexpression with pLysis RARE plasmid 
 After the unsuccessful attempt to overexpress PksS, a new vector was introduced 
to the overexpression system.  To force pksS to express genes rarely used by E. coli, the 
Rosetta plasmid (pLys RARE) was transformed into M15[pREP4] along with 
pQE60/pksS.  The transformation mixture was incubated on ice for 30 minutes, heat 
shocked, and then incubated at room temperature for 10 minutes.  One mL of LB was 
added before the cells were incubated at 37.0ºC for 1 hour.  The cells were then plated on 
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agar plates containing 34 μg/ml of chloroamphenicol, 30 μg/ml of kanamycin, and 25 
μg/ml of ampicillin and incubated overnight at 37ºC.  A colony was used to inoculate a 
starter culture that will be used for the overexpression of PksS.  Following incubation, the 
starter culture was used to inoculate TB containing 34 μg/ml of chloroamphenicol, 30 
μg/ml of kanamycin, and 25 μg/ml of ampicillin.  The overexpression culture was 
incubated in a shaker at 240 rpm at 37 ºC until the optical denisty at 595 nm reached 
0.500-0.600.  IPTG with a final concentration of 0.63 mM was added to the culture and 
incubation was continued for another 3 hours.  Following the induction, 10 ml samples 
were removed periodically and centrifuged at 8,000 rpm.  The cells were resuspended in 
2 ml of 50 mM potassium phosphate buffer, pH 8.0 and then assayed using carbon 
monoxide and sodium dithionite to determine if a P450 was present, detailed in III.E.1.  
All peaks reported were inconsistent with the presence of a cytochrome P450.  In 
combination with the assay, a 12% SDS-PAGE was used to determine if pksS had been 
expressed during the growth.  Approximately 1 mL of cells were removed from the 
culture and centrifuged at top speed for 5 minutes.  The cells were then resuspended in 1 
mL of water to remove any contamination and then centrifuged again.  The cells were 
resuspended in 80 μL of SDS-PAGE buffer.  Using information collected throughout the 
growth period revealed that PksS protein had not been produced.  For experimental 
purposes, the overexpression was repeated twice.  In one case, the protocol was followed 
as before.  In the second case, the concentration of IPTG was raised to 1.0 mM.   
In another attempt to overexpress pksS, other transformants, which tested positive 
for pksS (detailed in II.E.3), were used to inoculate several starter cultures.  Following 
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incubation, the starter cultures were used to inoculate Luria-Bertani (LB) cultures 
containing 0.5% yeast, 1.0% Bacto Tryptone, and 1.0% NaCl.  The overexpression 
cultures were grown for several hours until optimal density was reached.  At this point, 
they were induced with 0.63 mM IPTG and grown for three hours.  Throughout the 
overexpression, 1 mL samples were removed every hour and centrifuged for 5 minutes at 
top speed.  The cells were resuspended in 80μL of SDS-PAGE buffer and analyzed by 
SDS-PAGE.  The gel showed a dim band around 46 KDa, the expected size of PksS.  To 
increase the production of pksS, the media was prepared with 2% glycerol to enrich the 
culture.  The LB was inoculated using starter cultures containing colonies from a 
previous transformation and grown according to standard protocol.  Following 
incubation, 1mL samples were run through a SDS-PAGE.  The gel showed no bands.   
 The next attempt to overexpress pksS utilized the introduction of a 1% dextrose 
solution to LB.  Starter cultures were grown using colonies from the previous 
transformation containing 30 μg/ml of kanamycin and 25 μg/ml of ampicillin.  The LB 
was grown until it reached optical density and then induced with 1 mM IPTG.  Following 
induction, 1 mL samples were removed from the culture and run through a SDS-PAGE.  
Also, during the protein purification process, Ni-NTA column purification, samples (20 
μL) were removed from each wash and analyzed by SDS-PAGE.  The gels resulted in 
inconclusive information and the procedure was repeated again.   
 After several unsuccessful attempts to overexpressed pksS, colonies from the 
retransformation of pksS insert, pQE60, plysis RARE, and M15[pRep4] were used to 
inoculate starter culture 34 μg/ml chloramphenicol, 30 μg/ml of kanamycin, and 25 μg/ml 
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of ampicillin.  The cultures were purified and then retransformed into competent 
M15[pREP4] cells.  The transformation mixture was plated on agar plates containing 34 
mg/ml of chloroamphenicol, 30 μg/ml of kanamycin, and 25 μg/ml of ampicillin.  This 
transformation resulted in two different sizes of colonies, large and small.  Both sizes of 
the colonies were used to inoculate starter cultures containing 34 μg/ml of 
chloroamphenicol, 30 μg/ml of kanamycin, and 25 μg/ml of ampicillin.  Following their 
incubation, the starter cultures were used to inoculate LB containing 1% dextrose.  The 
cultures were induced using 0.63 mM IPTG when optimal density was reached.  During 
the growth period, several 1 mL samples were removed to determine if PksS was being 
produced using a SDS-PAGE.  The results were inconclusive and the cultures were lysed 
and centrifuged in preparation for purification using a Ni-NTA column.  During the 
purification, samples were removed from the washes and then analyzed by SDS-PAGE.  
The gel showed no conclusive evidence of PksS being expressed.   
II.D.6. Sequencing  
 After several unsuccessful attempts to clone and purify pksS using plasmids such 
as pQE60 and pLys RARE, the next step was sequencing pksS.  The insert was prepared 
for sequencing by transforming the insert and plasmid into competent M15[pREP4] cells.  
The colonies were grown in a starter cultures containing 30 μg/ml of kanamycin and 25 
μg/ml of ampicillin, centrifuged, and then purified using the “QIAgen QIAprep Miniprep 
Kit.”  The concentration of DNA was determined by measuring the absorbance of the 
plasmid and insert at 260 nm.  Upon receiving the results from the sequencing, it was 
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determined that our sequence lacked Guanosine 1111 reported for pksS from the genomic 
sequence for Bacillus subtilis.   
II.D.7.  Using new primers, PKSS UP SAA and PKSS DN2 SAA 
 After receiving the sequencing information, new primers were designed that 
would force the PCR to include G1111, if it was present.  The upstream primer, pksS UP 
SAA, and the new downstream primer, pksS DN2 SAA, 5' - 
CAAGTTCTAGATCTGGAAATCTCTTCAAAAGC - 3' (including the restriction site 
BglII) were used in PCR with the following conditions: a 30 second hold at 98.0ºC; 30 
cycles of 10 seconds at 98.0ºC, 30 seconds at 59.0ºC, and 30 seconds at 72.0ºC; then a 
hold of 5 minutes at 72.0ºC.  After polymerization, the product was purified and then 
digested in conjunction with pQE60 with the appropriate restriction enzymes for 3.5 
hours.  To inactivate the enzymes, the digested materials were incubated for 20 minutes 
in a 65.0ºC water bath.  The products were then purified using 0.7% low melting gel 
electrophoresis and extracted for ligation.  The three different concentrations for the 
ligation reaction were: insert:plasmid ratio for the 1st reaction was 2μL:1μL, for the 2nd 
reaction 5μL:1μL, and for the 3rd reaction 10μL:1μL. Each reaction was combined with 
water, ligase buffer, and T4 ligase and incubated overnight under the following 
conditions: 30 minutes at 37.0ºC, 2 hours at 23.0ºC, and then held overnight at 16.0ºC.  
 Following the incubation, the ligation mixtures were transformed into 
M15[pRep4]cells and plated on agar plates containing 30 μg/ml of kanamycin and 25 
μg/ml of ampicillin.  The colonies were used to inoculate several starter cultures 
containing the appropriate antibiotics.  Each culture was purified and then digested using 
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NcoI and BglII restriction enzymes to verify the addition of the insert into the plasmid.  
After obtaining the results showing that the 10 μL concentration of the ligation mixtures 
yielded the desired products, the plasmids were retransformed into M15[pREP4] .  For 
the purpose of sequencing and overexpression, the same colony was used to inoculate 
two starter cultures comprised of LB, dextrose, and 30 μg/ml of kanamycin and 25 μg/ml 
of ampicillin.  Following the incubation, one starter culture was purified, concentrated, 
and sequenced.  The second culture was used to inoculate an overexpression culture 
containing LB, dextrose, 30 mg/ml of kanamycin, and 25 mg/ml of ampicillin.  The 
culture was grown to optimal density and induced with 1.0 mM IPTG.  Subsequently, 1 
ml samples were removed and treated with SDS-PAGE buffer.  The samples were then 
analyzed by SDS-PAGE. The gel revealed that no pksS was being produced at any point.   
 Despite using primers that would force the PCR reaction to include G1111, 
sequencing still revealed an absence of G1111.  After determining the error in the 
sequence, the genomic database was searched for the next in frame stop codon.   
II.D.8.  Using a new downstream primer, PKSS LONG DN SAA  
After the sequence had been corrected, a new downstream primer pksS long DN 
SAA, 5' - GGGGCGTTTTGAAGATCTTTTTGAAAGTGAAACAGG - 3' (including 
restriction site BglII) was designed that reflected the lack of the guanosine 1111 and 
inclusion of the newly discovered portion of pksS.  Another PCR was performed using 
the new downstream primer and the upstream primer pksS UP SAA with the following 
conditions:  a 30 second hold at 98.0ºC; 30 cycles of 10 seconds at 98.0ºC, 30 seconds at 
60.5ºC, and 30 seconds at 72.0ºC; then a hold of 5 minutes at 72.0ºC.  The product was 
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purified using the “QIAquick PCR Purification Kit” and then digested using the 
appropriate restriction enzymes for 3.5 hours at 37.0ºC.  After purifying the restriction 
digest using a 0.7% low melting gel, three different ratios of the insert:plasmid, 2μL:1μL, 
5μL:1μL, and 10μL:1μL, were used in ligation reactions.  Each ligation reaction was then 
transformed into competent M15[pREP4] cells and plated onto agar plates containing 30 
μg/ml of kanamycin and 25 μg/ml of ampicillin.  A colony from the 2μL:1μL 
concentration plate was used to inoculate a starter culture containing the appropriate 
antibiotics.  Plasmids from each starter culture were then purified and concentrated.  
After being sequenced, it was determined that pksS was successfully cloned into the 
pQE60 plasmid, and all expected nucleotides were present in the correct sequence.   
II.D.9 Overexpression and purification of PksS  
Following the successful cloning of pksS into pQE60, another colony was 
removed from the 2μL:1μL ligation plate, and used to inoculate a culture containing LB, 
dextrose, 30 μg/ml of kanamycin and 25 μg/ml of ampicillin.  Following the incubation, 
the starter culture was used to inoculate an overexpression culture containing LB, 
dextrose and the appropriate antibiotics.  After reaching the optimum density of OD595 
0.500-0.600, the culture was induced using 0.63 mM IPTG and grown for three hours.  
The culture was purified as before using a Ni-NTA column.  Samples of the washes were 
collected and run through a SDS-PAGE. The gel showed that PksS had been purified and 
successfully eluted off of the Ni-NTA column.   
Due to the 1 M imidazole within the elution buffer, which could interfere with 
subsequent spectroscopy, the protein was purified again using a Sephadex G25 column 
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with a diameter of 1.3 inches and a column bed of 5.3 inches.  After the protein was 
added to the column, it was eluted using 50 mM potassium phosphate buffer at pH of 
8.00.  The Sephadex column was used rather than dialysis to purify the protein further.   
II.D.10.  Sequence Homology  
To identify the role of PksS in the biosynthesis of bacillaene, sequence homology 
was used.  The corrected DNA sequence was translated into the amino acid sequence and 
then used to search for any homologous sequences using the Basic Local Alignment 
Sequencing Tool (BLAST), a tool supplied by the National Center for Biotechnology 
Information.  A homologous protein was found after performing “Protein-protein 
BLAST” search.  The sequence was aligned with the published sequence of PikC From 
Streptomyces venezuelae.  The sequence, identified by 2BVJ, was opened in the Swiss-
modeling program, Deep View, to show the location of the heme relative to the active 
site.   
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CHAPTER III 
CHARACTERIZATION OF PKSS 
III.A. Introduction  
 After correcting the error within the published sequence of pksS and achieving a 
successful purification of the protein, the next step was to determine the function of PksS 
within the biosynthesis of bacillaene.  Using sequence homology from II.E.9, PksS has 
preliminarily been identified as a cytrochrome P450.  The next step will be to classify 
PksS as a P450 through experimental methods.  Once this is done, we will be able to 
determine the role of PksS in polyketide biosynthesis in Bacillus subtilis.   
III.B. Goals  
III.B.1. Identification of PksS as a P450  
Sequence homology performed in II.E.9, has preliminarily identified pksS as a 
cytochrome P450.  A major goal of this research was to classify pksS as a P450 through 
spectroscopy methods and characterize the function of PksS in the biosynthesis of 
bacillaene.   
To determine if PksS is a cytochrome P450, the carbon-monoxide complex assay 
was used, shown in figure III.1.  In this assay, PksS was combined with sodium 
dithionite, a reductant, and carbon monoxide.  The assay is able to determine if PksS is a 
cytochrome P450 because the carbon monoxide acts as an inhibitor by blocking the heme 
center from regenerating through the use of molecular oxygen (Ortiz de Montellano 
2005).  The assay was performed by first reducing the iron center from a charge of III to 
69 
 
 
II by sodium dithionite, followed by the binding of carbon monoxide.  This reduction and 
carbon monoxide binding is marked by a shift in wavelength from 420 nm to 450 nm, 
however, the shift does not remain at 450 nm.  Because the carbon dioxide complex is a 
reversible inhibitor, molecular oxygen will bond to the Fe (II) center and generate a Fe 
(II)-oxy complex as the carbon dioxide is released.  In the normal catalytic cycle of the 
enzyme, a second electron would be supplied to this complex by a reductase enzyme, 
generating the ferric peroxo-complex.  The peroxo- intermediate is cleaved by 
protonation of the terminal oxygen releasing water and forming the iron IV-oxo 
intermediate.  This species reacts with a substrate resulting in the hydroxylated product, 
which is then released and the cytochrome P450 is regenerated to its Fe (III) state (Ortiz 
de Montellano 2005).  For complex III and VI to be formed from complex II and IV, two 
electrons must be donated.  This is necessary for functional PksS, but we do not know 
what provides them in Bacillus subtilis.   
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FIGURE III.1. Mechanism of Carbon Monoxide Inhibition of PksS (Andersson 1991) 
 
 
 
 
 
 
All P450 enzymes have a characteristic visible absorption spectrum when reduced 
in the presence of carbon monoxide.  This inhibition is achieved through the addition of 
carbon monoxide.  The carbon monoxide covalently binds to the iron center, where the 
carbon donates electrons to the iron center through the sigma bond (Ortiz de Montellano 
2005).  During this donation, there is also a back-donation of electrons from the Fe (II) d-
orbitals to the unoccupied π*-orbital of the ligands.  This donation of electrons, leads to 
the reversible binding to Fe III.  This binding allows for the monitoring of the reduced 
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carbon monoxide complex of the iron center through a wavelength shift from 420 nm to 
450 nm (Ortiz de Montellano 2005).   
Following the determination of PksS as a cytochrome P450, strains of Bacillus 
subtilis will be screened for reduction capabilities.  Two strains in particular, Bacillus 
subtilis 168 and OKB105 will be used because of their genetic ability to produce 
bacillaene.  It is expected that PksS will become reduced when combined with an 
electron donor, such as NADPH and NADH, and the crude protein extracts.  This 
reduction of the Fe can be monitored by spectroscopy when carbon monoxide shifts the 
Soret peak from 420 nm to 450 nm.   
By performing the reductase experiment, two goals can be reached.  The first, 
more information of the function of PksS in the polyketide biosynthesis of bacillaene will 
be available.  Several hypotheses have been described earlier detailing the hypothetical 
role of PksS in polyketide metabolisms.  Through liquid chromatography mass 
spectrometry (LC-MS), it may be possible to determine whether bacillaene, 
dihydrobacillaene, or other compounds are the substrate for PksS.   
There are two types of reductases for the cytochrome P450 enzyme.  In Class I, 
the electrons are transported through a two-step shuttle in which ferredoxin (an iron-
sulfur complex) and a ferredoxin reductase is used.  This class is most commonly 
associated with mitochondria and bacterial P450s and can be identified by the use of 
NADH as the electron donor (Ortiz de Montellano 2005).  The second class, Class II, 
shuttles electrons through a single-membrane bound enzyme, NADPH reductase.  This 
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class is associated with microsomal P450s and utilizes diflavin reductases, containing 
FAD and FMN (Ortiz de Montellano 2005). 
III.B.2. Constructing pksS mutants  
 In attempts to characterize the role of PksS, a mutant of pksS will be constructed 
using Bacillus subtilis 168 as the genomic template.  In theory, disrupting pksS will 
ultimately lead to the disruption of the final product in the polyketide synthesis (Vagner 
1998).  Monitoring the products compared to the original extracts with liquid 
chromatography mass spectrometry may lead to some insight on the role of PksS in 
polyketide biosynthesis.   
For knockout mutation of pksS, the cloning vector pMUTIN4, shown in figure 
III.2 will be used.   This vector has been designed specifically for the inactivation of 
specific genes from Bacillus subtilis.  The pMUTIN plasmids have incorporated different 
characteristics into the vector that allow for the deactivation of Bacillus subtilis genes 
(Vagner 1998).  Along with gene inactivation, the plasmids contain the Pspac promoter, 
which controls the transcription of downstream genes through IPTG.  By controlling the 
downstream genes, the transcription and time induction of the mutated gene can be 
controlled.  The Pspac promoter also incorporates a modified lacI gene that can be 
induced within B. subilis (Vagner 1998).   
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FIGURE III.2.  pMUTIN cloning vector (Vagner 1998) 
 
 
 
 
 
 
 
pMUTIN4 cannot replicate within B. subtilis, however, it can replicate in E. coli 
using the ColE1 origin site.  This plasmid contains the β-lactamase gene, which allows 
ampicillin selection in E. coli.  This is important because E. coli can be used as the host 
to assemble the plasmid that will target pksS.  Since the plasmid lacks a Bacillus subtilis 
origin of replication, the only way the B. subtilis can survive erythromycin selection is 
through homologous recombination of the plasmid into the genome (Vagner 1998).  
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The knockout mutation is achieved by a crossover reaction, shown in figure III.3.  
The crossover of the vector into the genome disrupts the targeted gene and also 
incorporates antibiotic resistance and the lacZ and lacI genes (Vagner 1998). Using PCR 
and restriction digests, several screens will be preformed to ensure that the mutation of 
pksS was effective.    
FIGURE III.3.  Crossover reaction in pMUTIN4 (Vagner 1998) 
 
 
 
 
 
 
 
The Vagner group, which developed pMUTIN, found that the mutation process 
was optimal for an insert length between 250-300 bp.  We will therefore, amplify a ~300 
bp sequence from the middle of pksS using Taq polymerase and PCR.  Following the 
amplification, the insert will be ligated into pMUTIN4, via the multiple cloning site 
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(MCS).  The plasmid will then be transformed into Bacillus subtilis, resulting in a 
knockout mutation of pksS.   
III.C. Results  
III.C.1. P450 Assay  
The first step in characterizing PksS as a cytochrome P450 required the use of a 
P450 assay.  To perform this assay, cells from an overexpression culture were collected 
after induction with IPTG and resuspended in potassium phosphate, carbon monoxide 
and sodium dithionite (Phillips 1998).  If PksS is a P450, this treatment is expected to 
result in a shift in a Soret peak from 420 nm to 450 nm.  Using whole cells in this way 
demonstrated that PksS is producing cytochrome P450.  We confirmed this result with 
purified protein.  
To ensure that the PksS is the origin of a 450 nm Soret peak, protein obtained 
during the purification using a Ni-NTA column was collected and assayed.  Several 
controls were also run as a comparison for the data obtained.  The controls used were: 
PksS in 50 mM potassium phosphate buffer, pH 8.0; PksS, carbon monoxide, and 50 mM 
potassium phosphate, pH 8.0; and PksS, sodium dithionite, and 50 mM potassium 
phosphate.  The full reaction contained PksS, carbon monoxide, sodium dithionite, and 
50 mM potassium phosphate.  The following figures, figure III.4, III.5, III.6, and III.7, 
represent the data obtained from the purified protein from PksS.  
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Figure III.4. PksS in Potassium Phosphate Buffer, 50 mM 
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Figure III.5. PksS with carbon monoxide in potassium phosphate buffer, 50mM 
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Figure III.6. PksS with dithionite in potassium phosphate buffer, 50mM 
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Figure III.7. Full P450 reaction, containing PksS, CO, dithionite, and potassium 
phosphate Buffer, 50mM 
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 Figure III.7 shows that when PksS is combined with sodium dithionite (a 
reductant) and carbon monoxide, the heme center resulted in a wavelength shift from 420 
nm to 450 nm, which is characteristic of the heme-Fe+2 CO complex.   
III.C.2. Establishing a suitable P450 reductase system for PksS  
After classifying PksS as a cytochrome P450, two Bacillus subtilis strains were 
screened for P450 reductase activities.  Two specific strains have been identified as 
possible candidates for reducing PksS.  Both BS168 and OKB105, were chosen because 
they both have the pksX cluster.  After growing both strands in Landy media (a minimal 
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media) and LB media (a rich media), LB was determined to be the most effective 
growing media.  After growing both strains under aerobic conditions, the crude protein 
was extracted and stored for later use in experiments. 
 In assays for PksS reductase activity, each reaction was carried out under 
anaerobic conditions.  Any access to molecular oxygen will inhibit the iron center from 
being reduced when combined with carbon monoxide.  Rather than the P450, if any 
molecular oxygen is present, the reductase will reduce the molecular oxygen with NADH 
or NADPH.  In combination of protein extracts from the two different strains of Bacillus 
subtilis, different electron donors, NADH (Class I) and NADPH (Class II), were used for 
the reduction of PksS (Ortiz de Montellano 2005).     
To find a suitable reductase, PksS was combined with 50 mM potassium 
phosphate, pH 8.0, and NADH or NADPH.  After purging the cell with argon gas to 
maintain anaerobic conditions, the cell was further purged with carbon monoxide.  
Following the addition of crude extract from either BS168 or OKB105, PksS was 
expected to reduce to Fe II and form the carbon monoxide complex, shown through a 
shift in wavelength from 420 nm to 450 nm.  To ensure that we had conditions sufficient 
for measuring the reductase activity, a known cytochrome P450BM3, donated by Dr. 
Gregory Raner, was used as a positive control.  BM3 was used because it is a cytochrome 
P450, which contains a reductase fusion domain.  The demonstration of BM3 self-
reduction would indicate that our experimental conditions are sufficient for the assay of 
reductase activity with an uncharacterized system.  A spectrum recorded for this positive 
control with BM3 is shown in figure III.8.   
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FIGURE III.8.  BM3 control for reductase activity 
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The observation of a reduced carbon monoxide spectrum for BM3 provided 
insight that the conditions for generating this species were successfully met.  After 
determining that our reductase activity was achieved successfully with this positive 
control, we then turned to tests for PksS activity.  The first sample contained PksS and 
NADH in 50 mM potassium phosphate pH 8.0.  After purging the sample with argon gas 
and evacuating the system under high vacuum, the sample was purged with carbon 
monoxide for several minutes.  The protein-extracts, which presumably contained the 
reductase, were introduced to the PksS sample using a syringe needle.  The visible 
spectrum was taken, shown in Figure III.9.  The spectrum shows that BS168 protein 
extracts and NADH can reduce the heme within PksS.   
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FIGURE III.9.  BS168, NADH, and PksS in 50 mM potassium phosphate, pH 8.0 
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 Spectra were continually collected for 42 minutes to show the time-dependence of 
the PksS reduction.  Figure III.10 shows the peak at 450 nm continues to increase as the 
peak at 420 nm decreases.  The shift in wavelength represents the iron center being 
reduced from Fe (III) to Fe (II) with carbon monoxide binding to the Fe (II) state.  
 
 
 
 
83 
 
 
FIGURE III.10.  Complete reduction of PksS using Bacillus subtilis 168 crude extracts 
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The next combination that was analyzed was PksS and NADPH in 50 mM 
potassium phosphate pH 8.0.  The sample was purged with argon gas, evacuated, and 
purged again using carbon monoxide as before.  After the sample was prepared, BS168 
was added to the sample using a syringe needle and the visible absorption spectrum was 
taken, shown in figure III.11.  The sample was allowed to incubate for more than one-
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hour and scanned continuously to check for any reduction.  The spectrum shows that with 
the addition of NADPH, PksS was not reduced.   
FIGURE III.11.  BS168, PksS, and NADPH in 50 mM potassium phosphate, pH 8.0 
 
 
 
-0.05
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
400 410 420 430 440 450 460 470 480 490 500
Wavelength (nm)
A
bs
or
ba
nc
e
 
 
 
The third sample was prepared with PksS and NADH using the same procedure 
described previously.  After the sample was purged with carbon monoxide, OKB105 was 
added to the cuvette using a syringe needle.  The sample was then scanned for reductase 
activity, shown in figure III.12.  The spectra show that with the addition of NADH and 
OKB105 crude extract, PksS is not reduced into its P450 form.  Therefore, the 
combination of NADH and OKB105 do not have the capability to reduce PksS.  
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FIGURE III.12.  OKB105, PksS, and NADPH in 50 mM potassium phosphate, pH 8.0 
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The final sample was prepared by combining PksS and NADPH in a sealed cuvet.  
After purging the sample with argon gas and evacuating the system under high vacuum, 
the sample was then purged with carbon monoxide for several minutes.  Crude extract 
from OKB105 was injected into the cuvette using a syringe needle.  The sample was then 
scanned for any reductase activity, shown in figure III.13.  The absence of a peak at 450 
nm shows that the combination of OKB105 and NADPH was not effective in the 
reduction of PksS.   
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FIGURE III.13.  OKB105, NADH, and PksS, in 50 mM potassium phosphate, pH 8.0 
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III.C.3. Determining the role of PksS using LCMS  
After establishing a P450 reductase for PksS, LCMS was used to identify the role 
of PksS in the biosynthesis of bacillaene.  The first step of preparing the samples for 
LCMS required a large amount of PksS to be obtained.  After the protein was purified 
using both the Ni-NTA column and the Sepharose G25 column, the protein was kept cool 
until the procedure began.  Several cultures of BS39374, a strain of Bacillus subtilis, 
were prepared by growing in Landy media for two days.  After acquiring crude bacillaene 
through methanol extractions, the samples were combined with the crude PksS reductase, 
an electron donor, and PksS.  The samples were analyzed by LC-MS over a period of 45 
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minutes in which the organic mobile phase increased from 5% to 95%.  Some of the data 
obtained show peaks relating to the production of bacillaene and hydrobacillaene.  The 
chromatograms for the reactions listed in Table III.1 are shown below.  All 
chromatograms have been offset for clarity and to diminish the effect of drifting by the 
HPLC.  
FIGURE III.14.   Methanol extraction of bacillaene  
 
 
 
 
 
 The chromatograms show a major peak of 599 m/z, which is consistent with 
either hydrated bacillaene or hydroxylated dihydrobacillaene.  The other two less intense 
peaks, with 581 and 583 m/z, correspond to bacillaene and dihydrobacillaene, which has 
not been previously observed.  It is important to note that during the full reactions in 
which PksS and crude reductase was added to the sample, the peaks corresponding to 
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dihydrobacillaene are no longer present.  These results, although not conclusive, suggest 
that dihydrobacillaene may be the substrate for PksS.  In order to positively identify the 
role of PksS in polyketide synthesis, knockout mutations of PksS were designed to 
determine the possible product of this P450.  We expect to see a change in m/z in the 
chromatogram to determine the effect of PksS on bacillaene.  
III.C.4.  Construction of pksS Mutant 
After being unable to positively identify the full role of PksS in the polyketide 
synthesis of bacillaene by HPLC, mutants of pksS were generated using the cloning 
vector pMUTIN4.  After selecting a specific area of the gene to clone into pMUTIN4, 
shown in figure III.15, primers were designed to amplify this portion of the gene.   
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FIGURE III.15. Sequence alignment of corrected pksS highlighting the region used to 
clone into pMUTIN4.  
 
pksS corrected  1    atgcaaatggaaaaattgatgtttcatccgcatggtaaagagtttcatcacaatcctttt 60    
pksS mutant     1    ------------------------------------------------------------ 1     
 
pksS corrected  61   tcagttttaggacgatttagagaggaagagcccattcaccgatttgaattaaaacggttc 120   
pksS mutant     1    ------------------------------------------------------------ 1     
 
pksS corrected  121  ggagccacatatccggcctggttaattacccgatacgatgattgtatggcctttttaaaa 180   
pksS mutant     1    ------------------------------------------------------------ 1     
 
pksS corrected  181  gacaatcgaattacaagagacgtaaaaaatgtgatgaaccaagaacaaatcaaaatgctc 240   
pksS mutant     1    ------------------------------------------------------------ 1     
 
pksS corrected  241  aacgttagtgaagatatcgattttgtatccgatcatatgctggcaaaagacacacctgac 300   
pksS mutant     1    ------------------------------------------------------------ 1     
 
pksS corrected  301  catacccgcctgagatcacttgttcatcaagcatttactccccgaaccattgaaaatctg 360   
pksS mutant     1    ------------------------------------------------------------ 1     
 
pksS corrected  361  cgcggcagcattgaacaaattgctgaacagcttttagatgaaatggaaaaagaaaataaa 420   
pksS mutant     1    ------------------------------------------------------------ 1     
 
pksS corrected  421  gcggatatcatgaaatccttcgcttcccctttgccttttattgttatatctgaattgatg 480   
pksS mutant     1    --ggatatcatgaaatccttcgcttcccctttgccttttattgttatatctgaattgatg 58    
 
pksS corrected  481  ggaatcccaaaagaagatcggtcacagtttcaaatctggaccaatgcgatggttgatacc 540   
pksS mutant     59   ggaatcccaaaagaagatcggtcacagtttcaaatctggaccaatgcgatggttgatacc 118   
 
pksS corrected  541  tctgaaggtaatagagagctgacaaatcaggcccttcgtgaatttaaagattatatcgct 600   
pksS mutant     119  tctgaaggtaatagagagctgacaaatcaggcccttcgtgaatttaaagattatatcgct 178   
 
pksS corrected  601  aagctgatccatgacagaagaataaagccaaaagacgatttaatcagcaaacttgtgcat 660   
pksS mutant     179  aagctgatccatgacagaagaataaagccaaaagacgatttaatcagcaaacttgtgcat 238   
 
pksS corrected  661  gctgaggaaaacggcagcaagttaagcgaaaaagagctctattcgatgctgttcttgctc 720   
pksS mutant     239  gctgaggaaaacggcagcaagttaagcgaa------------------------------ 268   
 
pksS corrected  721  gttgtagccggccttgaaacaactgttaacttactcggctcaggcaccctcgcattgctg 780   
pksS mutant     268  ------------------------------------------------------------ 268   
 
pksS corrected  781  cagcacaagaaggaatgtgagaagctcaagcagcagcctgaaatgatcgctacagcggtt 840   
pksS mutant     268  ------------------------------------------------------------ 268   
 
pksS corrected  841  gaagaattgctgcgatacacctcacctgtcgttatgatggcaaatcggtgggccatcgaa 900   
pksS mutant     268  ------------------------------------------------------------ 268   
 
pksS corrected  901  gactttacatataaggggcattcgatcaaaagaggagacatgatttttataggcatcgga 960   
pksS mutant     268  ------------------------------------------------------------ 268   
 
pksS corrected  961  tctgccaatcgcgacccgaatttttttgagaaccccgaaatattaaatataaatcggtcg 1020  
pksS mutant     268  ------------------------------------------------------------ 268   
 
pksS corrected  1021 cctaatagacatatttcttttggttttggcattcatttctgcttaggagcgcctcttgcc 1080  
pksS mutant     268  ------------------------------------------------------------ 268   
 
pksS corrected  1081 aggctggaaggccacattgcatttaaagcacttttgaagagatttcctgatattgaactt 1140  
pksS mutant     268  ------------------------------------------------------------ 268   
 
pksS corrected  1141 gcggttgcacctgatgacattcaatggagaaaaaatgtctttttaagaggattagaaagt 1200  
pksS mutant     268  ------------------------------------------------------------ 268   
 
pksS corrected  1201 ctccctgtttcactttcaaaataa 1224  
pksS mutant     268  ------------------------ 268   
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After running a PCR with the primers, pksS MUTINUP and pksS MUTINDN, a 
gel electrophoresis was used to analyze the products, shown in figure III.16.  After 
purification, the mutated gene and pMUTIN4 plasmid were digested, shown in figure 
III.17, and then ligated together by T4 DNA ligase.  Six different concentrations of the 
insert were used to ensure successful ligation into the vector.  Each ligation reaction was 
then transformed into competent Nova Blue cells and plated onto agar plates.     
FIGURE III.16. Agarose gel of PCR product using pksS MUTINUP and pksS 
MUTINDN. 
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Following an overnight incubation, the colonies were used to inoculate starter 
cultures.  After purifying the starter cultures, the plasmids were screened for the insert.  
The first set of plasmids were screened using a restriction digest.  After digesting the 
plasmids with HindIII and SacI, the samples were analyzed using a 0.7% agarose gel. 
 Because the gel electrophoresis was difficult to analyze, a PCR was run on each 
plasmid using BS168 as a positive control.  The gel electrophoresis, figure III.17, showed 
positive hits for 23, 52, and 72.  The positive hits were then used in the transformation into 
Bacillus subtilis strain OKB105. 
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FIGURE III.17.  PCR of mutated plasmids, Lane 1: Molecular weight, Lane 2: 11, Lane 
3: 23, Lane 4: 31, Lane 5: 52, Lane 6: 72, Lane 7: 103, Lane 8: BS168 genomic 
template 
 
 
 
 
 
 Following the transformation into Bacillus subtilis, detailed in III.E.5, the 
genomic DNA plasmids were screened for insertion into the genome using PCR.  Using 
gel electrophoresis, four positive hits, 23, 72, 103 were found for the successful 
transformation of the mutated version of pksS/pMUTIN4 into Bacillus subtilis.   
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III.C.5.  Characterization using pksS mutant, methanol, and LCMS 
 Following the identification of 4 viable transformants containing the mutated 
version of pksS, the mutants were grown in Landy media for 2 days.  Each sample was 
analyzed by methanol extraction and applied to the Hewlett Packard Agilent 1100 series 
HPLC with a 5 μM Prevail C-18 column attached.  Chromatograms were collected using 
the LCQ Advantage Thermo Finnigan liquid chromatography coupled with electrospray 
ionization mass spectrometry detection .  The following figure, figure III.18, shows the 
mutants and controls extracted by methanol after a 48 hour growth period.  The two 
controls, BS168 and OKB105, show two peaks of 590 and 576.  The polyketide or 
compounds that these peaks correlate to are unknown. The next four peaks show a 
distinct peak at 581, possibly corresponding to bacillaene.  This peak is absent in the 
controls of BS168 and OKB105.  It is possible that in presence of PksS, bacillaene is not 
produced and some other polyketide is being synthesized.   
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FIGURE III.18. LCMS Chromatograms for Mutants of PksS in MeOH after 48 hour 
growth period. 
 
 
 
 
 
 
 
III.C.6.  Characterization using pksS mutant, acetonitrile, acetic acid, and LCMS  
 
 After several runs of the mutated PksS using methanol for extraction, the 5 μM 
Prevail C-18 column experienced a clog and was no longer functional.  After the arrival 
of a new column, a new method was chosen in hopes to prevent any precipitation of 
protein during the analysis.   
 To prevent the precipitation, methanol was replaced by a solution of 95:5 
acetonitrile: 1% acetic acid solution.  The mutants 21, 22, 31, and 32 were grown for 48 
hours and then triturated with the new solvent.  The samples were applied to the HPLC-
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MS and analyzed as before.  Figure III.19 shows the chromatograms obtained after a 45 
minute analysis of each sample.  The chromatograms show several distinct peaks at 597 
and 584.  Although these masses do not correspond to a known polyketide, it is possible 
the can be correlated to some unknown substrate for PksS.   
FIGURE III.19.  PksS mutants extracted by 95:5, acetonitrile: 1% acetic acid solution 
after a 48 hours growth period 
 
 
 
 
 
 
The cultures were allowed to continue to grow for another 24 hours, to achieve a 
total growth period of 72 hours.  The primary goal was to determine if there was any 
effect of the growth period of the polyketides that were being produced.  Figure III.20 
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shows that after an extra 24 hours of incubation, a distinct peak at 599 arises.  This peak 
may correspond to the production of hydroxylated bacillaene or hydrated 
dihydrobacillaene.  Assuming that pksS has been knocked out through mutations, it is not 
understood why a peak at 599 m/z is present.   
FIGURE III.20.  PksS mutants extracted by 95:5 acetonitrile: 1% acetic acid solution 
after a 72 hours growth period. 
 
 
 
 
  
 
In another attempt to determine any possible effects on the extraction of a 
polyketide, OKB105 was grown in different media.  Although OKB105 is a control, it is 
important to know the effect of the growing media on the desired polyketide.  Figure 
III.21 and figure III.22 shows that there is a significant difference in the masses produced 
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from the different types of media.  The issue, however, is that the masses obtained do not 
correspond to any expected polyketide.   
FIGURE III.21. OKB105 grown for 48 hours in Landy Media.  
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FIGURE III.22. OKB105 grown for 48 hours in LB media 
 
 
 
 
 
III.C.7 Characterization using pksS mutant, ethyl acetate, and LCMS  
 
 After receiving results that may correlate to the failed extraction of hydrated 
dihydrobacillaene or hydroxylated bacillaene, a new extraction solvent was used.  After 
triturating the lyophilized extracts with ethyl acetate, it was determined that the extract 
was insoluble in ethyl acetate.  The supernatant obtained from this extraction was applied 
to the HPLC-MS and analyzed for any production of a substrate.  Figure III.23 shows two 
distinct peaks of 576 and 590, possibly corresponding to the extraction of plastic from the 
microcentrifuge tubes used.  These masses show that no polyketides were extracted that 
corresponded to substrates of our interest.   
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FIGURE III.23. PksS mutants extracted in ethyl acetate after a 48 hour growth period 
 
 
 
 
 
 After failing to receive any results for the extraction of substrates by ethyl acetate, 
the pellets were then resuspended in 95% acetonitrile:5% 1% acetic acid.  The 
supernatant obtained from the resuspension was applied to the HPLC-MS and analyzed 
for the production of any compounds.  Figure III.24 shows that no masses were obtained 
that correlated to the desired polyketides, therefore, extraction by ethyl acetate was not 
successful. 
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FIGURE III.24.  PksS mutants after resuspension in ethyl acetate and acetic acid: 
acetonitrile after a 48-hour growth period 
 
 
 
 
 
III.D. Conclusion  
 After determining a critical error in the published sequence of pksS, it was 
important to determine if pksS would act as a cytochrome P450.  With the use of the 
carbon-monoxide complex assay, it was possible to identify PksS as a cytochrome P450.   
 With the combination of PksS with a reductase, sodium dithionite, and carbon 
monoxide, it was determined that PksS was indeed a cytochrome P450.  The 
characterization was achieved by monitoring the shift in wavelengths from 420 nm to 450 
nm.  A shift could be seen using purified PksS and crude PksS resuspended in 50 mM 
potassium phosphate, pH 8.0. 
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 After the successful determination that PksS is a cytochrome P450, the next step 
was to determine a suitable reductase for the reduction of the heme center.  Testing 
different strains, BS168 and OKB105, and different electron donors, NADH and 
NADPH, led to the establishment of a suitable reductase system.  The addition of NADH 
and BS168 to PksS under anaerobic conditions resulted in the reduction of the heme 
center and a change in wavelength.  The shift from 420 nm to 450 nm allowed for the 
identification of BS168 protein extract as reductase for PksS.  However, the addition of 
BS168 extract and NADPH did not result in the reduction of the iron center.  This 
information leads to the assumption that PksS is a member of Class I, NADH-dependent 
cytochrome P450s (Ortiz de Montellano 2005).  Also, there was no reduction of the heme 
upon the addition of OKB105 and either NADH or NADPH.   
 To determine the role of PksS in the biosynthesis of bacillaene or a precursor, the 
polyketides needed to be extracted from a known strain, BS39374 that carries the desired 
polyketide.  Using methanol extraction, two controls were used to compare to the 
production of a substrate upon the addition of PksS, an electron donator, and a reductase.  
The chromatograms show that in all samples, controls and full reactions, peaks 
correlating to hydrated bacillaene or hydroxylated bacillaene, bacillaene, and 
dihydrobacillaene are recorded.  The samples undergoing a full reaction show the 
disappearance of the peak correlated to dihydrobacillaene.  This leads to the preliminary 
assumption that the substrate for PksS is dihydrobacillaene.   
To obtain more information concerning the function of PksS in the biosynthesis of 
bacillaene, a mutant of pksS was constructed.  After efficiently cloning a position of pksS, 
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into the pMUTIN4 vector, then pksS/pMUTIN4 was transformed into competent Nova 
Blue (E. coli) cells.  The plasmids were screened for the insert by a restriction digest and 
PCR.  The plasmids 23, 52, and 72 were found to contain the insert and were transformed 
into Bacillus subtilis.  Following the transformation, the genomic DNA from three 
mutated strains were screened again using PCR.  The positive hits, 23, 72, and 103, were 
found to contain the mutated inserts.   
After obtaining extracts that contained the mutated pksS, the extracts from 
mutants and wild type strains were applied to the HPLC-MS to determine the role of 
PksS.  The first method, which used methanol as the extraction solvent, resulted in peaks 
that correlated to desired polyketides.  The controls, BS168 and OKB105, showed peaks 
of 590 and 576, which correspond to unknown compounds.  The mutants showed distinct 
peaks at 581, which corresponded to bacillaene.  This peak is absent in the controls of 
BS168 and OKB105, possibly showing that bacillaene is not produced to a significant 
amount when PksS is functional.   
To further the understanding the role of PksS and prevent the possibility of 
protein precipitation on the column, a different solvent was used.  A 95% acetonitrile:5% 
1% acetic acid solution was used to triturate the mutants after a 48-hour incubation.  The 
chromatograms showed several distinct peaks at 597 and 584.  Although these masses did 
not correspond to a specific polyketide, it is possible they can be correlated to some 
unknown substrate for PksS.  After increasing the incubation period to 72 hours, distinct 
peaks arose at 599 corresponding to the production of hydroxylated bacillaene or 
hydrated dihydrobacillaene.  This peak should not have been present in any mutated 
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versions of pksS if PksS hydroxylates the substrate.  We assume that the mutation may 
not have worked. 
Another solvent, ethyl acetate, was also used in an attempt to successfully extract 
the polyketide.  Although the pellets were not soluble in ethyl acetate, the samples were 
still applied to the HPLC-MS.  Chromatograms showed two distinct peaks of 576 and 
590, providing insight that no polyketides were extracted that corresponded to substrates 
of our interest.  The insoluble material was then resuspended in 95% acetonitrile:5% 1% 
acetic acid and applied once again to the HPLC-MS.  Again no information was obtained 
that would provide insight on the role of PksS in the biosynthesis of bacillaene or 
dihydrobacillaene. 
III.E. Future work  
 The results received during the analysis of the mutated pksS showed no consistent 
results.  Although several runs were attempted and analyzed, it was difficult to establish 
controls for the mutations.  A full reaction containing mutated PksS, an electron donor, a 
reductase, and an extract of bacillaene was attempted.  During this process, we 
experienced protein precipitation during the analysis with LCMS.  Our time was then 
dedicated to determining an efficient way to extract the mutants without causing protein 
precipitation. 
 To complete the characterization of PksS, future work will be dedicated to 
determining appropriate extraction methods.  A solid phase extraction method has been 
reported by Butcher et. al. (2007), in which the extract was successfully obtained and 
104 
 
 
analyzed using NMR techniques.  Future work will also be focused on a more stringent 
method of determining the correct incorporation of the mutation into the genome.   
III.F. Experimental  
III.F.1. P450 Assay  
The cytochrome P450 assay was performed using two different suspensions of 
PksS.  In the first method, PksS was extracted for the cell culture after induction with 
IPTG (Sigma).  Every hour, following induction, 10 mL of media were extracted from 
the culture and resuspended in 3 mL of 50 mM potassium phosphate, pH 8.0.  The cells 
were then divided into one-thirds and placed into cuvets.  Controls were also set up to 
determine the effect of carbon monoxide, potassium phosphate, pH 8.0, and the sodium 
dithionite on PksS.  The first control was a 1 mL mixture containing crude cells from the 
culture resuspended in 50 mM potassium phosphate, pH 8.0 and run through the Varian 
CARY 100 Bio UV-Visible Spectrophotometer.  The spectrophotometer scanned 
between 400 nm to 500 nm for P450 activity (Phillips 1998).  After determining that 
there was no P450 activity, shown by a strong peak at 420 nm, the next control was set 
up.  In the second control, one milliliter of the suspension was purged with carbon 
monoxide for 1 minute.  The cuvet was then placed into the UV/VIS and scanned for any 
P450 activity (Phillips 1998).  After determining the carbon monoxide had no effect 
when combined separately with PksS, the final control was set up.  In this control, 1 mL 
of crude PksS resuspended in 50 mM potassium phosphate buffer, pH 8.0, was combined 
with 5 mg of sodium dithionite (Phillips 1998).  After scanning the mixture for any P450 
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activity, it was determined that the components had no effect on PksS when combined 
separately.   
 After performing several controls, 1 mL of the PksS and 50 mM potassium 
phosphate, pH 8.0, was purged for one minute.  Following the purging, 5 mg of sodium 
dithionite was added to the cuvet and gently inverted to mix.  The sample was then 
placed into the cuvet and scanned for any P450 activity (Phillips 1998).  After obtaining a 
spectra showing a strong wavelength shift from 420 nm to 450 nm, it was determined that 
PksS was a cytochrome P450.   
 The next step in the cytochrome P450 assay was to use PksS purified by a Ni-
NTA column (Qiagen).  Before running the reactions, the protein was run through a 
Sepharose G25 column (Sigma-Alrich), molecular weight range of 100-5,000, to remove 
any residual imidazole from the purification process.  Controls were set as before, 
monitoring the effects of sodium dithionite, carbon monoxide, and the 50 mM potassium 
phosphate, pH 8.0. 
 The first control monitored the effects of potassium phosphate on PksS.  To 
monitor this effect, 150 μL of PksS was combined with 850 μL of 50 mM potassium 
phosphate, pH 8.0 (Phillips 1998).  After scanning the mixture for any P450 activity, it 
was determined that 50 mM potassium phosphate had no visible effects on the purified 
PksS.  The second control monitored the effects of the addition of sodium dithionite to 
PksS resuspended in 50 mM potassium phosphate.  The sample was prepared by 
combining 150 μL of PksS, 850 μL of 50 mM potassium phosphate, pH 8.0, and 5 mg of 
sodium dithionite (Phillips 1998).  The sample was then placed into the UV/VIS 
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Spectrophotometer and scanned from 400 nm to 500 nm for any possible P450 activity.  
After obtaining spectra showing no shift in wavelength from 420 nm to 450 nm, it was 
determined that the addition of sodium dithionite had no effect on PksS.  The final 
control was used to determine if the addition to carbon monoxide to resuspended PksS 
would cause and shift in the wavelength.  The control was performed by combining 150 
μL of PksS and 850 μL of 50 mM potassium phosphate, pH 8.0, in a cuvet and then 
purging the system for approximately one minute.  After purging, the cuvet was placed 
into the spectrophotometer and scanned for any reduction of PksS (Phillips 1998).  After 
determining the carbon monoxide had no effect on PksS, the full reaction was initiated.  
To perform a cytochrome P450 assay on PksS, 150 μL of PksS, 850 μL of 50 mM 
potassium phosphate were combined and purged with carbon monoxide for one minute.  
After purging with carbon monoxide, 5 mg of sodium dithionite were added and the 
cuvet was gently inverted to mix the sample.  The cuvet was then placed into the 
spectrophotometer and scanned for P450 activity (Phillips 1998).  The spectra showed a 
strong peak at 450 nm, representing the reduction and binding of carbon monoxide to the 
iron center.  
III.F.2   Assay for PksS reductase activity  
After classifying PksS as a cytochrome P450, several strains derived Bacillus 
subtilis were screened for their reduction capabilities.  Two specific strains, BS168 and 
OKB105, were screened because of their genetic capability to produce bacillaene through 
polyketide synthesis.  To prepare the strains for the reductase activity, starter cultures 
containing 5 ml of LB were inoculated with a colony of OKB105 and BS168, 
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respectively.  Following inoculation, the cultures were grown in aerobic conditions at 
37ºC, while being shaken at 240 rpm overnight in the New Brunswick Scientific C24 
Incubator Shaker.  The starter cultures were then used to inoculate different type of 
growing media to determine the optimal media.  One of the media used was a minimal 
media containing 1x Landy Salts, 2.0% D-glucose (Difco Laboratories), and 0.5% l-
glutamic acid (Fisher Science). The other media was LB, containing 1.0% Bacto-tryptone 
(Difco Laboratories), 0.5% Bacto-Yeast (Difco Laboratories), and 1.0% NaCl (Difco 
Laboratories).  Starter cultures were used to inoculate each of the medias and the cultures 
were allowed to grow for 2 days at 37ºC at 240 rpm.  After growing both strains in the 
media, it was determined that a nutrient rich media was efficient in the production of the 
reductase.  Any experiments carried out for the reductase utilize LB as the growing 
media.   
Following the two-day incubation period, both strains were centrifuged at 8,500 
rpm at 4ºC for 30 minutes.  The pellet was then resuspended in 50 mM potassium 
phosphate, pH 8.0, and lysed on ice using lysozymes (Fisher Science) supplied by Dr. 
Gregory Raner.  The suspension was then lysed further by sonication, using the Fisher 
Scientific 60 Sonic Dismembrator, and centrifuged at 11,500 rpm at 4ºC for 30 minutes.  
The supernatant was then removed and filtered through a 0.45 μm membrane (Fisher 
Science).  PksS was extracted using the methods described in Chapter II.E.8. 
 Samples were prepared for the reaction by combining 8 μM of PksS and 330 μM 
of NADH/NADPH (Sigma/AleXis Biochemicals).  The samples were brought to a final 
volume of 3 ml using 50 mM potassium phosphate, pH 8.0.  After preparing the sample, 
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the mixture was transferred into a cuvet and sealed with a rubber septum.  Using a 
Schlenck apparatus and needle, the sample was introduced into a controlled, anaerobic 
environment.  To remove any residue oxygen remaining in the cuvet, the system was 
purged with argon and evacuated using a high-pressure vacuum.  After repeating this 
process three more times, the anaerobic system was purged with carbon monoxide for 15 
minutes using a needle and appropriate venting.  After purging the sample, the system 
was scanned for any reduction of PksS.  A visible shift in wavelength from 420 nm to 
450 nm would ultimately lead to the determination of a suitable reductase for PksS.   
To ensure the apparatus was under anaerobic conditions, BM3, a known 
cytochrome P450 capable of complete reduction with the addition of carbon monoxide, 
was used as a control.  BM3, supplied by Dr. Gregory Raner, contains a reductase 
domain along with the P450 domain and is therefore capable of accepting electrons 
directly from a cellular reductant.  In order to set up the control, 8 μM of BM3 was 
combined with 83 μM of NADPH.  The system was then sealed with a rubber system and 
purged with argon.  After purging the sample, the system was then evacuated using a 
high-pressure vacuum. After repeating this process three times, the sample was the 
purged with carbon monoxide for 15 minutes via a needle and a ventilation needle.  After 
scanning the sample for the reduction of the heme, it was determined that the apparatus 
was set up correctly.   
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III.F.3. Determining function of PksS using LCMS 
 To determine the function of PksS in the polyketide biosynthesis of bacillaene, 
crude extracts must be obtained from BS39374, a strain derived from Bacillus subtilis.  
To prepare the strain for extraction of bacillaene, a starter culture of BS39374 was in LB 
overnight at 37ºC at 240 rpm.  The starter culture was used to inoculate a 50 mL culture 
of Landy media.  The culture was incubated at 37ºC for 72 hours at 240 rpm.  Bacillaene 
was extracted by combining 0.500 ml of the culture and 1 ml of HPLC-grade methanol 
(Pharmaco).  The sample was then vortexed for 20 seconds using the Vortex Genie and 
then centrifuged at top speed for 5 minutes in the Eppendorf Centrifuge 5415 C.  The 
supernatant was extracted and the methanol was removed by centrifugation extraction 
using the Savant Speed Vac SC110.  The system was evacuated using a Savant 
ValuPump VLP 120 while being maintained at a low temperature by the Refrigerated 
Vapor Trap RVT400 (by Savant).   
 Reductase strains, OKB105 and BS168, were prepared by inoculating starter 
cultures containing LB.  After an overnight incubation at 37ºC at 240 rpm, the cultures 
were used to inoculate 500 mL LB cultures.  These cultures were grown at 37ºC for 48 
hours at 240 rpm.  The reductases were extracted by centrifugation at 8,500 rpm for 30 
minutes at 4ºC in the Beckman Avanti J-25 Centrifuge.  The pellet was resuspended in 10 
ml of 50 mM potassium phosphate buffer, pH 8.0, and lysed on ice using lysozymes.  The 
suspension was also lysed by sonication.  After breaking down the cells walls, the media 
was centrifuged at 11,500 rpm for 30 minutes at 4ºC.  The supernatant was used for the 
subsequent reactions.  
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Samples used on the Liquid Chromatography Mass Spectrometer were prepared 
by combining 25.0% PksS, 10.7% of either NADH/NADPH, 10.7% of reductase, BS168 
or OKB105, and 53.6% of the bacillaene methanol extract to a total volume of 600 μL.  
After combining the respective components, each sample was incubated at room 
temperature for 1 hour and then filtered using a 0.45 μm membrane.  The samples were 
then transferred into Target DP™ Vials C4000-1 (National Scientific Company) and 
sealed with 9 MM Blue Caps T/S (Fisherbrand).  The vials were then placed into the 
Hewlett Packard Agilent 1100 series HPLC in which the 5 μM Prevail C-18 column 
(Alltech) was used.  Data was collected using the LCQ Advantage Thermo Finnigan 
liquid chromatography coupled with electrospray ionization mass spectrometry detector 
under the following gradient elution: begin at 95:5 1% acetic acid (Fisher 
Science):acetonitrile (Fisher Science), with the acetonitrile increasing to 95% over a 45 
minute linear gradient at 0.2 ml/minute flow rate.   
 To include each possible control and reaction combination, 13 different reactions 
were set up.  The following table displays the 13 different combinations used to obtain 
the most accurate data.  
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TABLE III.1 Reactions used in LCMS 
 
 
 
 Bacillaene 
MeOH, NSV 
Bacillaene 
MeOH 
PksS BS168 NADH NADPH 
Control 1 -  + - - - - 
Control 2 - + - + + - 
Control 3 - + + - + - 
Control 4 + - - - - - 
Full rxn - + + + + - 
Full rxn - + + + - + 
 
MeOH : methanol 
NSV : no speed vac 
 
 
III.F.4. Construction of pksS mutants  
After the obtaining inconclusive results for the methanol extraction of bacillaene, 
mutants of pksS were designed in hopes of determining the role of PksS in the 
biosynthesis of bacillaene.   Upstream and downstream primers were designed to amplify 
a 268 bp section of pksS.  The upstream primer pksSpMUTINUP and downstream primer 
pksSpMUTINDN were combined with Taq polymerase, dNTPs, and BS168 as the 
genomic template.  The PCR was run at the following conditions: 94.0ºC for two 
minutes; 30 cycles of 30 seconds at 94.0ºC, 30 seconds at 60.0ºC, and 90 seconds at 
72.0ºC; then a hold at 4.0ºC.  The PCR product was then analyzed by gel electrophoresis.  
After determining the product was the correct size, the product was purified using the 
“QIAquick PCR Purification Kit.”   
112 
 
 
The PCR product and pMUTIN4 plasmid were then digested separately with the 
restriction enzymes HindIII and SacI for 3.5 hours at 37.0ºC.  To inactivate the enzymes, 
the samples were then placed in a 65.0ºC water bath for 20 minutes (Vagner 1998). 
After incubation, a 0.7% low melting agarose gel was used to purify and measure 
the size of the material.  The bands were excised from the gel and incubated in a water 
bath at 75ºC.  The products were then combined at three different concentrations 
described here:  The insert:plasmid ratio for the 1st reaction was 2μL:1μL, for the second 
reaction 5μL:1μL, and for the 3rd reaction 1μL:2μL.  Each reaction was mixed with water, 
Ligase buffer, and T4 DNA ligase.  The samples were placed in a thermocycler overnight 
with the following conditions: 30 minutes at 37.0ºC, 2 hours at 23.0ºC, and then 4.0ºC for 
the remainder of the incubation.  The following day, each mixture was transformed into 
competent DH5α (E. coli) cells by combining 20μL of the ligation mixture to 100μL of 
the chemically competent cells.  The cells were incubated on ice for 30 minutes followed 
by a 2 minute incubation at 37ºC.  The samples were then incubated at room temperature 
for 10 minutes and then resuspended in 1 mL of LB media and incubated at 37.0ºC for 1 
hour.  Following the incubation, the cells were plated on agar plates containing 25 μg/ml 
of ampicillin and 30 μg/mL of kanamycin and incubated overnight at 37.0ºC. 
The cloning plasmid, pMUTIN4, was prepared by inoculating two starter cultures 
containing 5 mL of LB media and 25 μg/mL of ampicillin with pMUTIN4/DH5α.  The 
starter cultures were grown at 220 rpm overnight at 37ºC.  The following day, the 
cultures were purfied using the “QIAGEN MiniPrep Kit.”  The DH5α cells were made 
competent by inoculating a starter culture containing LB media with a colony of DH5α 
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and then grown at 220 rpm overnight at 37ºC.  The cultures were then spun down in a 
clinical centrifuge at maximum speed and then resuspended in 3 mL of CaCl2.  After 
incubating the cells on ice for 30 minutes, the culture was centrifuged again and then 
resuspended in 1 mL of CaCl2.   
After several failed attempts to grow the pMUTIN4/mutated pksS in DH5α, it was 
determined that the host cell had expired.  The next attempt utilized a different host cell, 
Nova Blue, for the overexpression of the mutated pksS.   
Nova Blue, which does not cause any sequence changes or contain any antibiotic 
resistance, was streaked onto an agar plate containing LB media.  After an overnight 
incubation at 37.0ºC, a starter culture containing LB media was inoculated using a 
colony.  The culture was then grown overnight at 220 rpm at 37.0ºC.  The cells were 
made chemically competent the following day using CaCl2. 
To prepare for transformation of pMUTIN4/mutated pksS into Nova Blue, the 
mutated pksS and pMUTIN4 were digest using HindIII and SacI.  The digested material 
were then analyzed and purified using a 0.7% low melting agarose gel electrophoresis.  
The DNA was the excised heated at 75ºC to melt the gel.  The products were then 
combined at three different concentrations:  The insert:plasmid ratio for the 1st reaction 
was 2μL:1μL, for the second reaction 5μL:1μL, and for the 3rd reaction 1μL:2μL.  Each 
reaction was mixed with water, Ligase buffer, and T4 DNA ligase.  The samples were 
placed in a thermocycler overnight with the following conditions: 30 minutes at 37.0ºC, 2 
hours at 23.0ºC, and then 4.0ºC for the remainder of the incubation.  The following day, 
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each mixture was transformed into competent Nova Blue cells by combining 20μL of the 
ligation mixture to 100μL of the chemically competent cells.   
The plasmids were transformed into the host cell by a series of heat and cold 
shock incubations.  The samples were then combined with 1 mL of LB and incubated at 
37ºC for 1 hour.  The cells were then centrifuged at 8,000 rpm for 5 minutes, 
resuspended, and then plated on agarose plates containing 25 μg/mL of ampicillin.  The 
plates were incubated at 37ºC overnight.  Several starter cultures were inoculated using 
colonies from each concentration of the ligation mixtures and then purified using the 
“QIAprep Spin Miniprep Kit.”   
The products were screened for the mutated insert acceptance using a restriction 
digest and PCR.  Although the restriction digest was not conclusive, the PCR screening 
was also used.  Positive hits were recorded for mutated pksS and pMUTIN4 containing 
the following concentrations of insert:plasmid: (3) 2 μL:1 μL, (5) 5 μL:1μL, (6) 5μL:2μL, 
(7) 10μL:1μL.  The purified plasmids were then retransformed into competent Nova Blue 
cells and plated on agar containing 25 μg/mL of ampicillin.  Starter cultures containing 5 
mL of LB media and 25 μg/mL of ampicillin were inoculated with the colonies from the 
previous reaction and grown overnight at 37ºC at 220 rpm.  Following the incubation, the 
cultures were purified using the “QIAGEN Miniprep Kit.”   
III.F.5 Transformation of mutant pksS into Bacillus subtilis 
 After obtaining plasmids with positive hits for the mutated insert, the plasmids 
were then transformed into competent Bacillus subtilis strain 168 cells.  To prepare the 
Bacillus subtilis 168 cells for transformation, an agar plate containing LB media was 
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streaked with a stock solution of BS168 cells.  The plate was placed in the incubator at 
37ºC for an overnight incubation.  Following the incubation, a starter culture containing 5 
mL of LB media was inoculated using one colony from the plate.  The culture was then 
placed in aerobic conditions at 37ºC overnight at 220 rpm.  The culture was centrifuges at 
top speed for 5 minutes and then resuspended in 1 mL of minimal media #1 
(Anagnostopoulos 1961).  
The composition of minimal media #1 was: 0.2% ammonium sulfate, 1.4% 
dipotassium phosphate, 0.6% monopotassium phosphate, 0.1% sodium citrate•2H2O, 
0.02% magnesium sulfate•7H2O, containing 0.5% glucose, 50 μg/mL L-Tryptophan, and 
0.02% casein hydrolyzate acid (Anagnostopoulos 1961).   
The solution was centrifuged again in a clinical centrifuge at top speed for 5 
minutes and then resuspended in 1 mL of fresh minimal media #1.  The cells were then 
incubated in a tube with a diameter of 17 mm at a 45º angle for 4 hours at 37ºC.  The 
cells were then centrifuged for 5 minutes at 3,000 rev/minute  and resuspended in a 10-
fold dilution of fresh minimal media #2 (Anagnostopoulos 1961).   
Minimal media #2 is comprised of 0.5% glucose, 50 μg/mL L-Tryptophan, 0.01% 
casein hydrolyzate acid, 0.2% ammonium sulfate, 1.4% dipotassium phosphate, 0.6% 
monopotassium phosphate, 0.1% sodium citrate•2H2O, 0.02% magnesium sulfate•7H2O, 
and an additional 5 μmoles/mL of magnesium sulfate•7H2O (Anagnostopoulos 1961).   
The 10 mL samples were divided into 1 mL samples and transferred into fresh 
tubes with the appropriate diameter.  The plasmids purified from the Nova Blue cells 
were then added separately to the tubes.  The following insert:plasmid concentrations 
116 
 
 
obtained in the previous reaction will be renumbered as follows:  (11) to 1, (23) to 2, (31) 
to 3, (52) to 5, (72) to 7, (103) to 10.  In order to achieve approved transformation, 1 μL 
and 2 μL of the purified plasmid were added to the competent BS168 cells.  To identify 
these samples, a subscript of either one or two denoting 1 μL or 2 μL will be added to the 
previous numbering.  The new numbering of the samples is as follows: 11, 12, 21, 22, 31, 
32, 51, 52, 71, 72, 101, 102. The samples were then incubated at a 45º slant for 90 minutes 
at 37ºC.  Following the incubation, the samples were centrifuges for 5 minutes at top 
speed and 950 μL of the supernatant was removed.  The transformants were resuspended 
in the remaining supernatant and then plated by using 20 μL of sample onto agar plates 
containing erythromycin and LB media.  The plates were incubated overnight at 37ºC.  
Colonies obtained from transformation were used to inoculate separate starter cultures 
containing 5 mL of MB media and 0.3 μg/mL (Anagnostopoulos 1961). 
After the overnight incubation, 8 starter cultures were chosen at random to be 
purified using the Promega “Wizard Genomic DNA Purification Kit.”  The samples 
purified are as follows: 22, 31, 51, 52, 71, 72, 101.  To purify the samples, 1 mL from each 
starter culture was centrifuged separately in a clinical centrifuge at top speed for 5 
minutes.  The pellet was resuspended in 480 μL of 50 mM EDTA and then combined 
with 120 μL of 5 mg/mL lysozyme solution.  The samples were incubated at 37ºC for 30 
minutes and then centrifuged at top speed for 5 minutes.  The pellets were resuspended in 
600 μL of Nuclei Lysis Solution and 3 μL of RNase solution.  After gently inverting the 
samples five times, 200 μL of protein precipitation solution was added.  The samples 
were vortexed vigorously for 20 seconds and then incubated on ice for five minutes.   
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Following the incubation, the samples were centrifuged at 13,200 rpm for 5 
minutes and decanted into sterile 1.5 mL centrifuge tubes.  To separate the DNA from the 
protein, 600 μL of isopropyl alcohol was added to the samples and then centrifuged for 2 
minutes.  The supernatant, containing the DNA, was carefully decanted and transferred 
into a new microcentrifuge tube.  The tube was gently inverted several times to allow for 
the precipitation of the DNA and then centrifuged.  The supernatant was decanted and the 
pellet was resuspended in 70% ethyl alcohol.  To wash the DNA, the tube was inverted 
several times and then centrifuged.  The supernatant was removed and the DNA was 
incubated at room temperature to remove any residual ethanol.  The DNA was rehydrated 
by incubating the samples at 4ºC overnight after adding 100 μL of DNA Rehydrating 
Solution.   
Following the 24 hour incubation period, the DNA was screened for proper 
insertion of the mutated gene using PCR.  To screen the plasmid for insert, the plasmids 
were used as the genomic DNA template, replacing BS168, and combined with the 
upstream primer, pksS UPMUTIN, the downstream primer, pksS DNMUTIN, dNTPs, 
and Phusion polymerase.  The PCR products were then screened for mutated pksS by gel 
electrophoresis.   
After receiving positive hits for the 21, 22, 31, and 32 mutated versions of pksS, the 
transformants were restreaked onto a new plate containing LB media and 0.3 μg/mL 
erythromycin.  Following an overnight incubation at 37ºC, a colony from each plate was 
used to inoculate starter cultures containing 0.3 μg/ml of erythromycin.  These starter 
cultures were used to make a stock concentration of the cells.  The stock solutions were 
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made by combining 850 μL of the culture and 150 μL of 80% glycerol in a sterile 
microcentrifuge tube.  The stock cells were stored in a –80ºC freezer.  All positive hits 
will be used in characterization reactions to determine the role of PksS in the polyketide 
biosynthesis of bacillaene.  
III.F.6.  Characterization using pksS mutant, methanol, and LCMS  
 After identifying positive hits of plasmids containing the mutated version of pksS, 
four samples, 21, 22, 31, and 32, of the pMUTIN4/mutated pksS in BS168 were used to 
inoculate separate starter cultures containing LB media and 0.3 μg/mL of erythromycin.  
For a control, two starter cultures contain LB media were inoculated with a colony of 
BS168 and OKB105.  The mutant cultures were grown under aerobic conditions at 37ºC 
for 72 hours at 220 rpm.  Following the incubation, 150 μL of each starter culture was 
used to inoculate 50 mL overexpression cultures of Landy minimal media.  The controls 
were grown under aerobic conditions at 37ºC for 48 hours at 220 rpm.  The media 
contained 1 mL of 1x Landy salts, 1 gram of dextrose, and 0.25 grams of L-glutamic 
acid.  5 M sodium hydroxide was added to the media to obtain a pH of 6.5.   
 The samples were analyzed for the effect of the mutated pksS by methanol 
extraction.  To extract the polyketide from each sample, 0.5 mL of the culture  was 
removed and transferred into separate 1.5 mL microcentrifuge tubes.  The samples were 
combined with 1.0 mL of HPLC-grade methanol and then vortexed vigorously for 1 
minute.  The samples were then centrifuged at top speed for 5 minutes and then decanted 
into clean, separate microcentrifuge tubes.  The samples were speed vacuumed at low 
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temperature to remove any methanol and then syringe filtered using a 0.45 μm nylon 
filter.  The extracts were transferred into HPLC vials and then analyzed using the  
Hewlett Packard Agilent 1100 series HPLC in which the 5 μM Prevail C-18 column 
(Alltech).  Chromatograms were collected using the LCQ Advantage Thermo Finnigan 
liquid chromatography coupled with electrospray ionization mass spectrometry detection 
under the following gradient elution: begin at 95:5 1% acetic acid:acetonitrile, with the 
acetonitrile increasing to 95% over a 45 minute linear gradient at 0.2 mL/minute flow 
rate.   
 To test the effect of different growing medias, two starter cultures containing LB 
media were inoculated with a colony of OKB105.  After an overnight incubation at 37ºC 
at 220 rpm, 150 μL of one starter culture was used to inoculate a 50 mL overexpression 
culture of Landy Minimal Media.  The second starter culture was used to inoculate a 500 
mL overexpression culture of LB media.  After a two day incubation at 37ºC at 220 rpm, 
samples were removed from both overexpression medias.  Bacillaene was extracted using 
the methanol extraction method and analyzed by HPLC-MS.   
III.F.7 Characterization using pksS mutant, acetonitrile, acetic acid and LCMS  
 
 After several extractions and runs of the methanol extracts on the 5 μM Prevail C-
18 column, the column experienced a fatal clog.  Following the order of a new column, 
new extraction methods were attempted to achieve conclusive results in determining the 
role of PksS in the polyketide biosynthesis of bacillaene or a precursor.  
 In an attempt to prevent the precipitation of the extract onto the column, the 
cultures were combined with the same percentage of solvents, 5% of 1% acetic acid and 
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95% acetonitrile, used during the analysis of the extracts.  To prepare the samples for the 
new method of analysis, starter cultures containing 5 mL of LB media and 0.3 μg/mL of 
erythromycin were inoculated with the mutants 21, 22, 31, and 32 and grown at 37ºC for 
48 hours at 220 rpm.  Following incubation, the 1 mL from each starter culture was 
transferred into a clean 1.5 microcentrifuge tube and centrifuged for five minutes at 
13,200 rpm.  The supernatant was decanted into a clean microcentrifuge tube and speed 
vacuumed for several hours at a low temperature.  The pellets were resuspended in 95% 
acetonitrile: 5% of 1% acetic acid and then vortexed vigorously for 2 minutes.  The 
samples were centrifuged at top speed for 5 minutes, decanted into clean centrifuge tube, 
and then syringe filtered using a 0.45 μm nylon filter into HPLC vials.  The samples were 
analyzed using the Hewlett Packard Agilent 1100 series HPLC in which the 5 μM Prevail 
C-18 column.  The chromatograms were collected using the LCQ Advantage Thermo 
Finnigan liquid chromatography coupled with ESI mass spectrometry detector under a 
gradient elution of 95:5 1% acetic acid:acetonitrile, with the acetonitrile increasing to 
95% over a 45 minute linear gradient at 0.2 ml/minute flow rate.   
 To determine the difference in 48 hours incubation versus 72 hours incubation, 
the mutants were allowed to grow for another 24 hours.  The extraction was followed as 
before using 5% of 1% acetic acid:95% acetonitrile as the solvent.  After triturating the 
samples, each sample was applied to the HPLC-MS for analysis.   
III.E.8 Characterization using pksS mutant, ethyl acetate, and LCMS  
 
 After receiving no concrete results, a new method was used to extract bacillaene 
from the cultures.  The next extraction method used ethyl acetate as the resuspension 
121 
 
 
solvent during the trituration.  The samples were prepared by making starter cultures 
containing 5 mL of LB media and 0.3 μg/mL of erythromycin that were inoculated with 
the mutants 21, 22, 31, and 32.  150 μL of the starter cultures were added to inoculate 50 
mL Landy media cultures and were grown at 37ºC for 48 hours at 220 rpm and then.  
Following incubation, the 1 mL from each starter culture was transferred into a clean 1.5 
microcentrifuge tube and centrifuged for five minutes at 13,200 rpm.  The supernatant 
was transferred into a microcentrifuge tube and speed vacuumed for several hours at a 
low temperature.  In an attempt to resuspend the pellets, 1 mL of ethyl acetate was added 
to the pellet and the vortexed vigorously.  After several minutes, the pellets were proved 
insoluble in ethyl acetate.  The supernatant from the first extraction attempt was removed, 
transferred into a microcentrifuge tube, and recentrifuged.  The supernatant was 
transferred to HPLC vial and applied to the HPLC-MS.  The pellet that was determined to 
be insoluble in ethyl acetate, was then resuspended in a 95% acetonitrile:5% 1% acetic 
acid solution.  The samples were centrifuged and the supernatant was transferred into 
HPLC vials.  The samples were then applied to the HPLC-MS for analysis.   
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